Inkeverse Group Announces 2024 Interim Financial Results ACN Newswire

Inkeverse Group Announces 2024 Interim Financial Results

HONG KONG, Aug 30, 2024 - (ACN Newswire via SeaPRwire.com) - Inkeverse Group Limited ("Inkeverse" or "the Group", Stock Code: 3700.HK) announces its full-year results for the period ended June 30, 2024.During the reporting period, the Group’s total revenue was RMB 3533.2 million, up 13.0% compared to the same period in 2023. Revenue from the Group’s value-added services was RMB 2601.2 million,yoy 12.4%, representing 73.6% of the Group’s overall revenue. The content services business recorded total revenue of RMB 642.7 million,yoy 36.1%, accounting for 18.2% of the Group’s overall revenue.Live Streaming and Social Ecosystem Thrives, Creating a Sustainable Development LoopThe Group’s live streaming and social business, through long-term stable operations and continuous refinement, has built a robust commercial ecosystem. The core product, "Inke Live," maintains its brand advantage in the live streaming sector. Despite market fluctuations, it has created a healthy, active user community through a mature and evolving operational system and ongoing optimization of the ecosystem structure.The social business continues to benefit from its product matrix advantage, adapting flexibly to the increasingly diverse and refined needs of users. The Group adjusts its strategy with an efficient product matrix to precisely match emerging social scenarios, deeply penetrating multiple verticals, and satisfying differentiated social needs, demonstrating strong market adaptability. The stable and innovative operation of the Group’s two core businesses provides stable and substantial cash flow support, effectively driving the Group’s deep expansion and continuous innovation in more business areas.Playlet Business Leads the Industry, Secure Industry-Leading Position with Full Industry Chain LayoutIn the face of intensifying competition in the short -form video market, the Group remains at the forefront of the industry due to its forward-looking layout and innovation. By leveraging early precision entry and efficient investment strategies, the Group has rapidly established a complete ecosystem for the playlet industry, optimizing the entire chain from content creation to distribution and promotion, ensuring steady business growth. This underscores the Group’s deep understanding of the playlet field and lays a solid foundation for continued industry leadership.Looking ahead, the Group is cautiously advancing the deep integration of playlets with cultural tourism and other diverse industries, aiming to create a series of high-quality, high-grade micro-playlet to offer a richer audiovisual experience to viewers. Simultaneously, the Group is exploring new opportunities in overseas playlets, broadening its business scope through internationalization. Breakthrough in Overseas Expansion, Successfully Opening New MarketsThe Group continues to deepen its overseas strategy and has achieved results. Leveraging its rich experience in the domestic market, the Group adopts a vertically segmented matrix strategy to rapidly enter target markets. To better meet local needs, the Group integrates rich local elements into product design, enhancing market competitiveness. Some products launched in Southeast Asia have successfully completed commercial validation, providing valuable experience and models for expansion into other regions. This year, the Group has entered emerging markets such as the Middle East, launching products and achieving a certain level of user accumulation.By continuously optimizing product models and deeply understanding overseas user needs, the Group has significantly shortened the adaptation cycle in new markets and accumulated valuable localized operational experience. This experience not only lays a solid foundation for the Group’s deep expansion in overseas markets but also provides strong support for further exploration in these markets.Future OutlookLooking ahead, the Group will continue to gain insights into user needs, enrich the social product matrix, and solidify competitive advantages through matrix-based synergy while exploring new growth points through innovation. Relying on its deep accumulation in interactive entertainment, the Group will quickly incubate new products, optimize content quality, enhance user experience and platform stickiness, and maintain its leading position in the market. Simultaneously, the Group is actively adjusting its overseas operations strategy, deepening localization, enriching product formats, and expanding efforts in emerging markets such as Southeast Asia and the Middle East, aiming to achieve scalable growth. Additionally, the Group is keeping up with technological frontiers, actively laying out Web3.0 and AI fields, planning strategic cryptocurrency holdings, and promoting AI applications to lead industry future development and create new interactive entertainment experiences.-End-About Inkeverse Group Limited: Inkeverse Group (3700.HK) is a leading full-scenario new social platform in China, formerly known as Inke Interactive Entertainment Group. It’s core business covers live streaming social, playlets, and overseas segments, driving performance growth through a matrix of products and diversified business formats. In 2015, the first product, Inke Live, was launched, initiating the domestic mobile live streaming trend. In 2018, Inke, just three years after its establishment, was listed on the Hong Kong Stock Exchange as the first entertainment live streaming stock. Since then, the Group has incubated multiple products around the "interactive social" strategy, creating a rich social product matrix. In the second half of 2022, the Group pioneered the short drama market, firmly establishing itself as an industry leader with its early advantage and high-quality content. The Group is also accelerating its global layout and expanding overseas market growth. In 2022, the Group officially renamed itself Inkeverse and is actively laying out AI, Web3.0, and other cutting-edge fields to offer users rich, multidimensional social scenarios and services, further enhancing commercial value.For more information, please visit Inkeverse IR website: https://ir.inkeverse.com/sc/ir_overview.phpFor enquiry, please contact Intelligent Joy Limited Copyright 2024 ACN Newswire via SeaPRwire.com.
More
AGAPE ATP Corporation Addresses Recent Corporate Exercise and Strategic Developments ACN Newswire

AGAPE ATP Corporation Addresses Recent Corporate Exercise and Strategic Developments

KUALA LUMPUR, Aug 30, 2024 - (ACN Newswire via SeaPRwire.com) - AGAPE ATP Corporation (NASDAQ: ATPC) (“ATPC” or “the Company”), is pleased to announce a series of significant updates reflecting its ongoing commitment to growth and sustainability.Effective today, ATPC will implement a 1-for-20 reverse stock split of its shares of common stock, as previously disclosed in filings with the Securities and Exchange Commission. This strategic action aims to increase the market price per share, thereby meeting NASDAQ's continued listing standards and ensuring the Company’s position on a globally recognized exchange. Additionally, the number of authorised shares of common stock will be reduced from 1,000,000,000 to 50,000,000.Beyond the reverse stock split, ATPC is advancing several strategic initiatives aimed at strengthening its position and providing value to shareholders. The Company is planning to launch new products expected to enhance its financial outlook and market presence. The recent partnership with B&H Intec Solution Sdn. Bhd, which led to the formation of ATPC Green Energy Sdn. Bhd., has lined up a promising pipeline in its green energy sector. This venture is an important step in expanding the Company’s capabilities in sustainable energy solutions, aligning with its broader goals of supporting environmental sustainability.Furthermore, ATPC is actively expanding its offerings in the wellness and senior care sectors. Cedar ATPC Sdn. Bhd. is poised to introduce a range of new wellness services designed to meet the growing demand for health and wellness solutions. At the same time, Sweet Home Senior Living Care Centre Sdn Bhd continues to thrive, delivering high-quality care services to address the needs of an aging population. These initiatives underscore the Company’s commitment to enhancing the quality of life and supporting sustainable development, which are core pillars of its business strategy.Financially, the Company remains on solid footing, with a strong balance sheet and sufficient liquidity to support ongoing and future initiatives. ATPC is also exploring new opportunities in both domestic and regional markets, particularly in the areas of Wellness and Green Energy, as part of its strategy for sustainable growth.The Company recognises the concerns of its investors regarding the reverse stock split and wants to assure them that these actions are part of a broader strategy to ensure long-term stability and growth. While short-term market dynamics can be influenced by various factors, including geopolitical events and economic shifts, ATPC is confident in the underlying strength of the markets in which it operates and its strategic positioning within them. The management team is closely monitoring market conditions and remains prepared to take swift, decisive actions to protect and enhance shareholder value. Copyright 2024 ACN Newswire via SeaPRwire.com.
More

Tong Ren Tang Chinese Medicine Announces 2024 Interim Results

HONG KONG, Aug 30, 2024 - (ACN Newswire via SeaPRwire.com) Beijing Tong Ren Tang Chinese Medicine Company Limited (“Tong Ren Tang Chinese Medicine” or the “Company”, Stock code: 3613.HK) is pleased to announce the unaudited results of the Company and its subsidiaries (collectively referred to as the “Group”) for the six months ended 30 June 2024 (the “Period”).In the first half of 2024, facing challenges such as the sustained strength of the Hong Kong dollar, changing consumption patterns, and a sluggish retail industry in Hong Kong, China and Macau, China regions, the Group responded proactively and made simultaneous efforts from multiple dimensions of products, marketing, research and development, and production. This ensured the stable operation of its business and the continued consolidation of its market-leading position. During the Period, the Group achieved revenue of HK$ 664.5 million, net profit of HK$ 240.3 million, and profit attributable to owners of HK$ 219.8 million, with earnings per share of HK$ 0.26.By market segment, during the Period, the Group further enriched its product matrix and optimized its retail market layout. The Hong Kong, China market achieved revenue of HK$333.8 million, with 30 retail terminals, a net increase of 3 terminals compared with the previous year. In the markets outside Mainland China (excluding Hong Kong, China,), the Group accelerated its brand market expansion and steadily promoted its internationalization, achieving revenue of HK$214.4 million. In addition, the Group achieved revenue of HK$116.3 million in Mainland China market.Sufficient momentum from technological innovation, new breakthroughs in production and R&DThe development of science and technology has provided new technical support and growth strategies for the advancement of traditional Chinese medicine (“TCM”). During the Period, the Group leveraged technological innovation as a driving force, empowering intelligent upgrades in production and enhancing product excellence and innovation. This has helped accumulate new momentum for future growth and supported the inheritance and innovation of TCM.Product quality is the lifeline of an enterprise. At the production level, the Group’s production and R&D base in Tai Po consistently upholds stringent standards and rigorous procedural controls. The Group has successfully secured Hong Kong, China’s GMP and ISO22000 certifications, with its product quality has been recognized. Additionally, to further enhance the cost competitiveness of its products, the Group has intensified efforts in revamping and upgrading its production layout. By increasing mechanization and automation, the Gorup has effectively reduced production costs and boosted productivity, thereby ensuring consistent product availability in the market.In terms of products, the Group intensifies its R&D efforts, actively diversifying its product matrix and expediting the translation of scientific research outcomes. During the Period, the Group completed the production of a number of new registered proprietary Chinese medicines and health food products, including Guizhi Fuling Wan , Lingzhi Turmeric Compound Blood-supplementing and Nerve-calming Capsules , Wolfberry Coffee Mix , Red Ginseng Coffee Mix and Sporoderm-broken Ganoderma Lucidum Spores Chocolate . The Group also plans to commence the production of Qiyao Pills ) and Jinshui Liujun Jian Granules. In April this year, the Group’s self-developed product, Danggui Buxue Keli, were awarded the Certificate of Registration of Proprietary Chinese Medicines (HKC-18604) issued by the Chinese Medicine Council of Hong Kong, China, further enriching the Group’s product portfolio. In May this year, the Group’s invention patent (Patent Number: ZL 2023 1 1206874.8) for “a freckle-removing and whitening product along with its preparation method and uses was successfully granted by China National Intellectual Property Administration and has been applied to Ageing-Defying Collection of the Tong Ren Tang’s Chinese anti-aging NMN series.In addition to preserving and advancing TCM services, the Group is also expanding into new health concept areas. During the Period, the Group entered into a Memorandum of Understanding with Deer Industry New Zealand to promote innovative health-functional deer food products, assisting both parties in collaborative development, registration and marketing efforts. The Group will give full play to strengths in both its proprietary brand and Chinese medicine, combined with the resource advantages provided by New Zealand, the origin of deer velvet, to accelerate the R&D of New Zealand deer products and the deployment of the industrial chain configuration, and continue to expand into new health domains.Moving forward, the Group will continue to strengthen its cooperation with internationally renowned institutions and research organizations such as the University of Hong Kong, Hong Kong Baptist University and the University of California, to conduct research on the safety and mechanism of key products such as Tong Ren Tang’s Angong Niuhuang Wan , Ganoderma Lucidum-related products and Tong Ren Niu Huang Qing Xin Wan, in order to further expand its scientific research results, and to provide a reliable scientific basis for the entry of its products into the mainstream markets overseas in the future. The Group adheres to the highest standards of superior, pure and genuine traditional Chinese medicinal materials, and brings together the essence of the intangible cultural heritage culture and exquisite craftsmanship, as well as strict and meticulous production to fully embody the Group’s motto: “Never cut corners on labour and quality, no matter how complex the process or how costly the materials”. This philosophy not only enhances the health value delivered to customers but also provides the Group with a stronger growth momentum.Orderly market expansion and diversified marketing to strengthen brand effectIn terms of market expansion, on the one hand, the Group has continuously introduced new products to consolidate and expand its market share. During the Period, the Group launched new products, including the Tong Ren Tang’s Chinese anti-aging NMN series – the Youth Prime Collection and the Age-Defying Collection, the Guizhi Fuling Wan , and Wood Lok Medicated Oil , broadening its product range. At the same time, the Group further expanded its retail presence in Hong Kong, China by opening three new retail outlets in North Point, Mong Kok, and West Kowloon. The North Point and West Kowloon stores also offer Chinese medical consultation and treatments to reach a wider customer base.In terms of product marketing, the Group has intensified its marketing efforts to increase product recognition. Specifically targeting the “major variety” products, such as Tong Ren Tang Angong Niuhuang Wan and Sporoderm-broken Ganoderma Lucidum Spores Powder Capsule and Tong Ren Niu Huang Qing Xin Wan, the Group promoted and advertised the brand and products through an omni-channel approach, integrating special festivals and themes to create consumer hotspots. Moreover, the Group has also advanced the development of both online and offline channels, continuously expanding its sales channels to meet the demands of post-pandemic era business models.In terms of brand promotion, the Group capitalized on its participation in major events, significantly enhancing its promotional efforts and accelerating the brand market expansion. During the Period, serving as a critical portal for Beijing Tong Ren Tang’s international development, the Group participated in the 2024 Wuzhen Health Conference, showcasing its flagship products and a variety of new products. In implementing the “Belt and Road” initiative, the Group leads time-honored brands venture into the world and integrates into the international arena. By adopting the “bring in” and “go global” strategy, the Group is promoting the rich and profound TCM culture, further disseminates Chinese health wisdom globally to benefit more people.Additionally, the Group has enhanced its brand image and influence through public welfare activities. The Group has actively encouraged its overseas retail outlets that offer Chinese medical consultations and treatments to provide charity Chinese medicine clinic services. This initiative embodies the Group’s philosophy of “introducing medicine through treatments” and supports its brand development. In Hong Kong, China, the Group has fully supported and participated in public welfare activities, demonstrating to society and the public the Group’s corporate spirit of “Nurturing kindness and virtue, preserving tranquility and wellness ”. Through its services and products, the Group is dedicated to deeply embedding the Tong Ren Tang brand, products and Chinese medical consultation and treatments services into the community, spreading the culture of Tong Ren Tang while encouraging a healthy lifestyle among community residents.Future ProspectsWith the ongoing economic and social development, an intensifying aging population trend, and the increasing health awareness among residents, the pharmaceutical consumption market is expected to expand continuously. TCM, as a crucial sector of the pharmaceutical industry, continues to hold significant potential for growth in the global market.In the future, the Group will continue to strengthen R&D efforts and expand its proprietary product matrix, including products such as Ganoderma Lucidum series and anti-aging series, to create diversified growth engines and drive the realization of high-quality developmental transformation within the Group. At the same time, the Group will focus on business development by enhancing its new retail layout, accelerating the introduction of new products, continuously advancing the registration of Tong Ren Tang’s key products in Vietnam, innovating business models, and reinforcing its core competitive advantages. By leveraging the development of new quality productive forces as its engine, the Group strives to achieve sustained growth in its business scale. Copyright 2024 ACN Newswire via SeaPRwire.com.
More

Wuling Motors’ Net Profit Surges 72.3% in H1 2024

HONG KONG, Aug 30, 2024 - (ACN Newswire via SeaPRwire.com) - Liuzhou, a key industrial hub in Southwest China, has long been a pioneer in China's industrial history. From manufacturing Guangxi's first automobile and aircraft before the founding of the People's Republic of China to becoming the second-largest industrial city in South China during the reform era, Liuzhou has consistently thrived with the times.Today, as Chinese automotive companies expand globally, Liuzhou's businesses are once again at the forefront, with Wuling Motors (0305.HK) serving as a prominent example.On August 22, Wuling Motors announced its interim results for 2024, demonstrating strong performance across its three main business segments. The company is actively enhancing its high-quality production capabilities and exploring growth opportunities abroad, achieving impressive results in its international ventures.In the first half of 2024, Wuling Motors made significant strides in its overseas expansion: exporting auto parts to Vietnam, golf carts to Egypt, and new energy logistics vehicles to South Korea, as well as establishing a research and development center in Hong Kong...Wuling Motors is sending a clear message to the world: The company's future is bright, with limitless potential.(I) Moderate Growth in Auto Parts and Other Industrial Services RevenueAccording to Wuling Motors' 2024 interim report, the company achieved a revenue of CNY 3.946 billion in the first half of this year, with a gross profit of CNY 426 million. Net profit surged 72.3% to CNY 21.125 million compared to the same period last year.Breaking down the segments, the auto parts and other industrial services business recorded a revenue of CNY 2.698 billion in the first half of the year, up 6.1% year-on-year. During this period, Wuling Motors focused on consolidating its existing market while aggressively expanding into new territories. The company aimed to break into growth markets dominated by giants like Great Wall Motors, Chery, and BYD. Sales to newly acquired customers surged to CNY 1.042 billion, accounting for 38.6% of the divisional revenue.Wuling's Jingmen base in Hubei, dedicated to supplying Great Wall Motors, rapidly scaled up its production, generating CNY 334 million in revenue in the first half of the year. It successfully delivered frame assemblies for two Great Wall models, breaking the record for the highest first-month delivery of a new product. Additionally, Wuling's domestic ultra-high-strength steel tube hydroforming production line - a first in China - successfully commenced mass production, supplying 13 hydroformed products to premium models from brands like Great Wall and BYD.The auto parts and other industrial services segment posted an operating profit of CNY 75.883 million in the first half of the year, up 44.3% year-on-year.In the automotive power systems segment, Wuling Motors achieved CNY 902 million in revenue. While strengthening its traditional power technology upgrades, Wuling Motors accelerated its layout of new energy power integration development, speeding up its new energy business initiatives. In the first half of 2024, Wuling accelerated the establishment of a comprehensive product matrix for hybrid and battery electric powertrains and core components, advancing production capacity and rolling out new products and technologies. By promoting its products, Wuling Motors has focused on building lines and improving processes for motors, motor controllers, rotors, and stators, securing new energy market collaborations with JAC Motors and Changan Kaicene.The commercial vehicle segment posted CNY 331 million in revenue in the first half of the year, primarily seeking breakthroughs in high-value-added sub-sectors.Wuling Motors achieved a gross profit margin of 10.8% in the first half of 2024, a significant increase of 270 basis points from 8.1% in the same period in 2023. This impressive growth was largely driven by declining prices for raw materials, such as steel. Additionally, the ramp-up of higher-margin products further contributed to the substantial improvement in the company's profitability.(II) Striking the Main Chord of Overseas ExpansionIn the 1960s and 1970s, Liuzhou's tractors were exported to Vietnam and Rwanda in Africa, and in 1990, its microcars were shipped to Thailand. Liuzhou-made vehicles have consistently ventured overseas.Today, Liuzhou's automotive industry faces another historic opportunity for overseas expansion.As domestic market demand becomes saturated, expanding abroad has become essential for Chinese companies, and overseas markets are emerging as the new "blue ocean."For example, Guangxi's exports were robust in the first half of the year. According to customs statistics, Guangxi's import and export trade reached CNY 345.28 billion in the first half of 2024, up 12% year-on-year. Exports alone hit CNY 191.8 billion, a record high, rising 28.5%. Exports of major categories like mechanical and electrical products and labor-intensive products were CNY 109.18 billion and CNY 37.3 billion, respectively, growing by 26.8% and 48.5% and accounting for 56.9% and 19.4% of Guangxi's total exports.In the automotive market, "intense competition" and "overseas expansion" are the current hot topics. According to the China Association of Automobile Manufacturers (CAAM), in July 2024, China exported 469,000 vehicles, up 19.6% year-on-year. From January to July 2024, China's auto exports reached 3.262 million units, up 28.8%. Among these, exports of battery electric vehicles totaled 554,000 units, and plug-in hybrid vehicles reached 154,000 units, representing a 180% increase year-on-year.Specifically in Liuzhou, more than 90,000 vehicles were exported through Liuzhou Customs in the first half, up 23.8% year-on-year; of these, over 10,000 were new energy vehicles (NEVs), a surge of more than 30-fold.Wuling Motors has seized this trend, charting a course for global success.Take the Wuling golf cart as an example. With its strong handling, lightweight design, comfortable ride, and powerful performance, the Wuling golf cart has been highly favored by overseas customers. Since its launch, it has been sold in countries across Southeast Asia, Central Asia, Europe, and America.Earlier this year, Wuling Industrial, a subsidiary of Wuling Motors, showcased its new multi-purpose golf/community vehicles at the 71st PGA Merchandise Show in Orlando, USA, drawing significant attention. On April 15, the 135th Canton Fair kicked off in Guangzhou, where Wuling Industrial's golf carts attracted buyers from 205 countries and regions worldwide. On May 22, Wuling Industrial shipped about 200 golf carts to Egypt, expecting to complete delivery in the third quarter.Wuling Motors' joint venture, Wuling New Energy, also broke new ground with its G050 left-hand drive battery electric logistics vehicle. In March 2024, the company secured its first order of 300 units with South Korea's Daechang Corp, marking a breakthrough in the Korean market.Currently, Wuling's sightseeing vehicles, golf carts, and other products are exported to countries such as Vietnam, Singapore, Thailand, the USA, and Australia. Its new energy logistics vehicles have also penetrated traditional automotive powerhouses or regions such as the USA, Japan, and Europe, laying a solid foundation for expanding into the international market.This achievement is due to Wuling Motors' strategic planning.In recent years, Wuling Motors has accelerated its overseas expansion, with subsidiaries in India and Indonesia continuing to strengthen their presence. These efforts, focused on promoting the localization and launch of new models with key clients, have proven highly effective, helping Wuling penetrate new customer bases and meet international standards.On the product side, Wuling Motors has further enriched its product lineup, with more auto parts poised to enter global markets. In a major breakthrough, Wuling's self-developed rear drive axle assembly and drive system assembly for new energy passenger vehicles successfully entered the overseas market in the first half of this year. This achievement marks a departure from the traditional three-section axle housing structure, instead adopting a hydraulic expansion integral axle housing technology, which has been well-received by customers. On the channel side, Wuling is leveraging Hong Kong as an export conduit for its new energy business, boosting overseas sales for the group and its joint ventures.On the research and development front, Wuling Motors has established an innovation center in Hong Kong and signed memoranda of understanding (MOUs) with Hong Kong Polytechnic University (PolyU) and the Chinese University of Hong Kong (CUHK) to focus on NEV technology, jointly promoting the conversion and application of scientific research results.(III) Driving Global Growth Through High-Quality ProductionIn global competition, technology reigns supreme. Wuling Motors has been a pioneer in the NEV sector, steadfastly pursuing the development of NEVs. With a goal of deriving more than 50% of its business from NEV operations, Wuling is laying a solid foundation to become a front-runner in the new energy vehicle era as it ventures into overseas markets.In the auto parts business, Wuling Motors continues to align with the "passenger-focused" and "electrification" upgrades of its customers' products, continuously developing passenger vehicle products while actively supporting new energy vehicle models for major customers.Currently, Wuling Motors has successfully developed and optimized a range of products, including new energy electric rear axles, motors, motor controllers, range extenders, and hybrid systems. This year, the production of core components such as electric axles and hybrid engines has seen steady growth.After surpassing the milestone of producing one million units of micro electric axles, Wuling's coaxial electric drive axle became the first to achieve commercialization in China. It has been adopted by brands such as Changan Kaicene, Ruichi, and JAC Motors. Wuling Motors also secured orders from leading companies like Chery and Geely for electric axles used in mainstream NEV commercial vehicles. At Wuling's Jingmen base, which supplies auto parts to Great Wall Motors, business has flourished, with over 50% of its products sold in the first half of 2024 being NEV parts, generating CNY 333 million in revenue.In automotive power systems, Wuling Motors has made remarkable progress in developing and mass-producing high-efficiency engines and new energy power systems. Their strategy seamlessly integrates traditional power technology upgrades with new energy power innovations, resulting in a robust product lineup. In the first half of 2024, Wuling Motors focused on enhancing production lines and processes for motors, motor controllers, and rotors and stators. The H-platform ultra-high-efficiency engine has been successfully commercialized, securing projects with NEV clients like JAC, Changan, and Skyworth. Additionally, Wuling's casting sales reached 515,000 units, up 26.2% compared to the same period in 2023.In the commercial vehicle segment, Wuling focuses on specialized modification markets such as cold chain vehicles, sanitation vehicles, and medical vehicles. Their specialty products, including refrigerated trucks, sanitation trucks, and fire trucks, have been delivered to regions like Shandong, Zhejiang, Hunan, and Beijing. Leveraging its customization capabilities, Wuling has partnered with PepsiCo to develop a "mobile new retail" model, delivering over 100 Wuling vending trucks to PepsiCo and accelerating the expansion of mobile commerce.Wuling's joint venture, Wuling New Energy, is actively upgrading its brand and market position. They launched the long-range Golden Storage Mid-size Logistics Vehicle to quickly capture market share, achieving monthly sales exceeding 1,000 units in the first three months after launch. Additionally, Wuling New Energy is aggressively expanding into international markets, increasing exports to countries such as the USA, Japan, and South Korea. In the first half of 2024, Wuling New Energy sold approximately 7,900 NEVs, a 68.1% increase compared to the same period in 2023.It is evident that Wuling Motors' strategic direction is becoming increasingly clear.With a comprehensive business layout and a full range of products, Wuling has created synergies across its industrial chain, positioning itself as Guangxi's most comprehensive leading automotive group in the supply chain. With unparalleled control over product quality, cost, scale, and customer relations, Wuling has built a formidable competitive advantage.As the NEV era rapidly approaches, Wuling Motors is fortifying its dominant businesses, focusing on high-tech, competitive, and high-end flagship auto parts, expanding markets for high-value specialized modified vehicles, and advancing its NEV key parts and vehicle business.With these foundations, Wuling is boldly venturing overseas, aiming for growth through globalization and efficiency in management, poised for even higher-quality development in the new era. Copyright 2024 ACN Newswire via SeaPRwire.com.
More
TIME Interconnect Technology Limited Announces Interim Results For the Six Months Ended 30 June 2024 ACN Newswire

TIME Interconnect Technology Limited Announces Interim Results For the Six Months Ended 30 June 2024

HONG KONG, Aug 30, 2024 - (ACN Newswire via SeaPRwire.com) TIME Interconnect Technology Limited (“TIME Interconnect”, Stock Code: 1729.HK, with its subsidiaries collectively referred to as the “Group”) is pleased to announce its interim results for the six months ended 30 June 2024 (the “Current Interim Period”).During the Current Interim Period, the pace of economic expansion has been slow, owing to the factors, such as still-high borrowing costs and withdrawal of fiscal support, and the increasing geo-economic fragmentation and geo-politic tension. In spite of these challenges and difficulties, the Group strives to improve its business operations and financial position by proactively seeking potential investment opportunities that would diversify the Group's existing business portfolio, broaden its source of income and enhance value to the shareholders of the company. Benefiting from the AI boom, the revenue of data centre sector and specialty cable sector have significantly increased by 16.6% and 93.6% respectively during the Current Interim Period and the profitability was relatively improved. In addition, the Group paid more attention and efforts in the medical equipment cables business, and with the setup of two new plants, the revenue of medical equipment sector has also significantly increased by 166.0%. At the same time, the Group has completed its investment in two medical and healthcare-related companies in July 2024. The overall profitability of cables and wires has also improved due to these sectors are carrying a better margin. Meanwhile, overseas orders for networking cable sector continued to improve. The revenue of networking cable sector has increased by 25.1% during the Current Interim Period.For the Current Interim Period, the Group recorded revenue amounting to HK$2,666.1 million, represented an increase of HK$39.4 million or 1.5% as compared with HK$2,626.7 million for the six month ended 30 September 2023 (“Previous Interim Period”). Operating profit for the Current Interim Period was HK$309.2 million, represented an increase of HK$74.1 million or 31.5%, as compared with HK$235.1 million for the Previous Interim Period, with the operating profit margin raised from 9.0% to 11.6% for the Current Interim Period. The increase of operating profit was mainly attributable to changes of product mix, higher revenue from medical equipment, data centre and specialty cable sectors with all three market sectors having better profit margin; and lower revenue and profit margin from the server sector.For the Current Interim Period, basic earnings per share was HK10.4 cents, which is 33.3% higher than the basic earnings per share of HK7.8 cents in the Previous Interim Period. The Board Directors of the company is pleased to declare an interim dividend of HK1 cent per share, amounting to a total of approximately HK$19.5 million.Business ReviewThe Group’s turnover by market sector is as follows:Market SectorTurnover (HK$ million)Share of TurnoverSix months ended 30 June 2024Six months ended 30 September 2023ChangesSix months ended 30 June 2024Six months ended 30 September 2023Cable assembly Data centre564.4484.116.6%21.2%18.4% Telecommunication286.5348.6-17.8%10.7%13.3% Medical equipment386.0145.1166.0%14.5%5.5% Industrial equipment21.312.866.4%0.8%0.5% Automotive68.469.5-1.6%2.6%2.7%Digital cable Networking cable614.7491.225.1%23.0%18.7% Specialty cable111.557.693.6%4.2%2.2%Server613.31,017.8-39.7%23.0%38.7%Total2,666.12,626.71.5%100%100%Data centre sectorThe emergence of Al drove the growth and development of the Group's data centre business. During the Current Interim Period, the revenue of data centre sector increased by HK$80.3 million or 16.6% to HK$564.4 million as compared to HK$484.1 million for the Previous Interim Period due to the upgrading of servers and the profitability was relatively improved. Orders from this sector maintained at a high shipment level during the Current Interim Period, and remained the highest revenue sector in the cable assembly business.Telecommunication sectorIt recorded a decrease of revenue from HK$348.6 million for the Previous Interim Period to HK$286.5 million for the Current Interim Period, represented a decrease of HK$62.1 million or 17.8%. The main customers of telecommunication sector are located in PRC, and the main reason for the decline in revenue was the impact of the Lunar New year holidays during the Current Interim Period as compared to the Previous Interim Period.Medical equipment sectorDuring the Current Interim Period, the Group paid more attention and efforts in the medical equipment cables business and continued to enhance its medical equipment customers base, as well as to strengthen its R& D capabilities during the Current Interim Period. Benefited from the setup of two new plants, Time Kunshan and Time Jiangxi, last year and expanded production capacity and R&D capabilities for medical equipment cables products, the revenue of medical equipment sector has significantly increased to HK$386.0 million, represented an increase of HK$240.9 million or 166.0% as compared with HK$145.1 million for the Previous Interim Period.Industrial equipment sectorThe global economy recovered but the pace was slower than expected. The divergences between countries have maintained. High interest rates directly raised the cost of borrowing and constraining economic activity. However, there was slight improvement in the industrial equipment sector. The revenue of industrial equipment sector increased by 66.4% from HK$12.8 million for the Previous Interim Period to HK$21.3 million for the Current Interim Period.Automotive sectorThe revenue of automotive sector was HK$68.4 million for the Current Interim Period, compared with the revenue for the Previous Interim Period of HK$69.5 million, represented a slight decrease of 1.6%. Affected by geopolitics and trading war, the sales orders of automotive wire harness products maintained a lower level during the Current Interim Period. But the Group still believes that the automotive wiring products can help the Group to provide its customers with a broader product portfolio. To capture opportunities brought by the booming electric vehicle market, the Group’s new wholly-owned subsidiary, Linkz Cables Mexico, S. de R.L. de C.V. ("Linkz Mexico"), has been setup in Mexico to increase its market share in markets outside China and Asia.Networking cable sectorEven a lot of negative factors, such as the divergences between countries, wars, high interest rates, strong US dollar and high inflation, were remained exist, overseas orders for networking cable sector continued to improve. The revenue of networking cable for the Current Interim Period was HK$614.7 million, represented an increase of HK$123.5 million or 25.1% as compared with HK$491.2 million for the Previous Interim Period. The rise in copper price indicated that market demand is continuing to improve. The establishment of Linkz Mexico also helps to increase its market share in the U.S. and Mexico markets.Specialty cable sectorSame as data centre sector, Al also stimulated the growth and development of high-speed cables in the specialty cable sector. For the Current Interim Period, the revenue of specialty cable was HK$111.5 million, represented a significant increase of HK$53.9 million or 93.6% as compared with HK$57.6 million for the Previous Interim Period. High-speed cables also carried a better profit margin which benefited to the Group's overall profitability.Server sectorFor the Current Interim Period, the revenue of server was HK$613.3 million, represented a decrease of HK$404.5 million or 39.7% as compared with HK$1,017.8 million for the Previous Interim Period. After a peak of new products shipments at the end of last year, there was a shortage of key components supply this year, resulting in some orders need to be rescheduled.ProspectLooking ahead, on the downside, geopolitical tensions and high interest rates continue to dampen global economic activities. According to the latest forecast of the "World Economic Outlook" issued by the "International Monetary Fund" in 2024, global growth estimated at 3.2 percent in 2023, is projected to continue at the same pace in 2024 and 2025. The latest forecast for global growth five years from now at 3.1 percent is at its lowest in decades. On the upside, inflation could fall faster than expected amid further gains in labor force participation, allowing central banks to bring easing plans forward. Artificial intelligence and stronger structural reforms than anticipated could spur productivity. However, even the Group is facing such challenges and difficulties in the macro-economic environment, the management remains confident in its future business. With the support of Luxshare Group, the Group enjoys advantages in both product manufacturing capabilities and financial strength. The Group will continue to develop strategic businesses and markets, strengthen its business foundation and achieve impressive results during the economic downturn.The Group believes that the PRC’s continued acceleration of 5G technology research and development, as well as the new social normals caused by the epidemic, including work-from-home and online meetings, are expected to drive the demand of cable assembly products and telecommunication sector and benefit the Group’s business growth. In light of this, the management remains confident in 5G-related business.On the other hand, considering the vigorous development of the automotive and electric vehicle markets, the Group believes that the automotive wire harness products can help the Group to provide its customers with a broader product portfolio, and to step in new business sector by enriching the Group's business portfolio and broadening its unique customer base, helping the Group to capture opportunities brought by the booming electric vehicle market. In view of these, the Group has setup a new wholly-owned subsidiary, Linkz Mexico in Mexico to increase its market share in markets outside China and Asia. A new plant is expected to be put into production in the second half of 2024. The new factory will produce digital cables and automotive wire harness products. This is a "China-Plus-One" strategy, which can protect supply chains and export markets against geopolitical tensions and unforeseen disruptions and enable the Group to capture market opportunities upon the arrival of this generation 5G network.Moreover, the utilisation rate of cloud technology in the companies around the world is continuously increasing, which is expected to drive the development of data centre. Meanwhile, the development of 5G will boost the application of big data, IoT, internet gaming and video streaming through cloud platform. To capture the huge market demand, the Group extended its business to server sector, the products offered by the Group under this business are mainly applied in data centres. Having considered that (i) China is actively conducting investment activities to build digital infrastructure; (ii) the PRC manufacturers continue to increase the share of local supply chain due to geopolitics relationship; and (iii) Luxshare Precision has extensive technological knowhow and good customers’ relationships, the Group is optimistic on the potential demand in the market. Meanwhile, the emergence of Al drove the growth and development of the Group's server and data centre sector business. However, geo-economic fragmentation continues to intensify, barriers to the flow of goods, capital and people continue to increase, and supply chain problems continue to arise. All of these have created challenges on the business operations of the Group. The Group will work very hard to find any business solutions to cope with the current economic environment as well as the complex geopolitical relationship around the globe, and continue to expand and consolidate the development of server business.As for the medical equipment sector, the Group expects the demand for medical equipment cables will continue to bring positive impact to the Group’s medical equipment cables orders this year. To catch up with the trend, the Group has established two wholly-owned subsidiaries, Time Kunshan and Time Jiangxi, to expand production capacity and R&D capabilities for medical equipment cables products.Moreover, the Group completed the investment in two medical and health related companies in July 2024. One is Cosmic M.E. Inc. (“CME”), which has become a subsidiary of the Company following its share subscription. With a proven operating history of over 30 years, CME is engaged in the developing, manufacturing and selling of electronic medical instruments and other medical equipment and devices. The Group believes that the subscription will allow it to leverage on CME's extensive knowhow and existing production facilities to immediately deliver reliable and high quality medical products to its existing and new customers. It will certainly bring synergy to both parties for the development of medical related products in terms of R&D, manufacturing capabilities and global market expansion. Another one is Valkyrie Industries Limited ("Valkyrie"), the company entitled shareholding 16.75% by share subscription. Valkyrie is a UK based startup with 7 years' long professional experience in haptics and virtual reality. It has developed haptic technology with patents, which can create weight, resistance and assistive forces for users in virtual simulations. It combines fitness, wellness and gaming for optimising human performance for the huge markets of games and neuromuscular recovery. The Group considered that the Valkyrie's technology will be a good opportunity for the Group to extend its product mix offered to the existing major customer and also tap into the new business sector so as to diversify the Group's business portfolio and broaden its income stream with distinct customer base. Besides, a new liaison office, Time Interconnect America Inc., has been established in San Diego since July 2024 to seize more business opportunities in medical-related markets. Moving ahead, the Group believes that this sector will maintain its dynamic pace of growth, considering the arising demand from the medical equipment market. The Group will pay more attention and efforts in this sector and continue to enhance its medical equipment customers base, as well as to strengthen its R&D capabilities.Riding on the PRC government's policy of "Channelling Computing Resources from the Eastern Areas to the Western Regions", Luxshare Precision will deploy the platform advantages and market position of the Luxshare Group and introduce strategic resources to the Company with intention to further strengthen the Company's potential for continuous growth and core competitiveness in its market and to enable the Company to develop strategically to become an all-rounded network solutions and infrastructure provider, so as to create greater value for the shareholders. In this regard, Luxshare Precision is conducting a strategic review of the operations and financial position of the Company, and actively exploring business opportunities for the growth and development, in both organic and inorganic manners, for the Company. The Company believes that, with the support of Luxshare Precision, the Group will create more and more possibilities in the future.– End –About TIME Interconnect Technology LimitedTIME Interconnect Technology Limited is a well-established supplier of customised interconnect solutions with over 30 years’ experience in the industry. The Group is headquartered in Hong Kong, and has manufacturing facilities in Shanghai, Suzhou, Jiangxi and Huizhou, the People’s Republic of China (“PRC”), Japan and Mexico. The Group currently manufactures and supplies a wide variety of copper & optical fiber cable assemblies, digital cable products, medical products and servers which are produced to the specifications and designs of its individual customer partners. Its products are used by a number of established PRC and international customers in a variety of market sectors, including telecommunication, data centre, industrial equipment, medical equipment, automotive wire harness, digital cables and server.This press release is disseminated by Bright Communications International Limited on behalf of TIME Interconnect Technology Limited. Copyright 2024 ACN Newswire via SeaPRwire.com.
More

Fosun Pursues Solid Business Development with Predictable Profit

HONG KONG, Aug 30, 2024 - (ACN Newswire via SeaPRwire.com) - On 28 August 2024, Fosun International (HKEX: 0656) announced its 2024 interim results. During the reporting period, its revenue continued to grow, reaching RMB97.84 billion. Industrial operation profit maintained growth, reaching RMB3.47 billion, and profit attributable to owners of the parent was RMB720 million.Guo Guangchang, Chairman of Fosun International, said at the results presentation on the morning of 29 August, “In the first half of the year, although the macro environment remained challenging, we resolutely executed our strategy of focusing on core businesses, developing industry-leading companies and products in the industries where we have formed advantages. Such strategy has been proven effective in general. Looking ahead, we will remain focus on innovation and globalization, while focusing on asset-light operations, driving long-term development with competitive core strengths.”Since the beginning of 2024, the domestic economic recovery has been rocky and the international market has remained volatile, which has brought challenges to Chinese companies including Fosun. Fosun steadfastly pushed forward its strategic focus, driving development with core strengths, achieving quality and efficiency improvement in core industries, and maintaining a solid asset base.Analysts believe that, based on Fosun’s interim results, Fosun’s focus on the core industries in the household consumption sector and its proactive approach to driving innovation and globalization have further reinforced its business foundation, resulting in predictable stable profits. Additionally, over the past two years, Fosun has actively pursued asset-light operations, optimized asset portfolio, and continued to reduce leverage. These efforts have resulted in abundant cash reserves and a stronger financial cushion, which are expected to prompt the market to reassess Fosun’s value.Staying ahead in globalization and innovation, reinforcing business foundation to develop industry-leading companies and products In the first half of the year, Fosun’s four core subsidiaries, namely Fosun Pharma, Yuyuan, Fosun Insurance Portugal, and Fosun Tourism Group (“FTG”), achieved total revenue of RMB72.17 billion, accounting for 74% of the Group’s total revenue. Fosun’s strategy of focusing on core businesses has shown increasing benefits, with its advantages in core industries such as pharmaceuticals, tourism, consumption, and insurance continue to be strengthened.With years of effort in the aforementioned sectors, Fosun has developed a number of industry-leading companies and products.For example, in the first half of this year, Fosun Pharma, which ranks second among the top 100 pharmaceutical companies in China, was selected as one of top 20 global pharmaceutical companies in terms of pipeline scale for the third consecutive year. Shanghai Henlius is the first Chinese profitable innovative biopharmaceutical company listed in Hong Kong, with multiple independently developed monoclonal antibody biosimilars that are driving the rapid development of China’s biopharmaceutical industry. Its first blockbuster product, HANLIKANG, is the first domestic biosimilar approved for marketing. Fosun Insurance Portugal holds the largest market share in the Portuguese insurance market and ranks among the leaders in the insurance sector across Portuguese-speaking regions globally. Easun Technology, in the intelligent manufacturing segment, is a global leading automation and digitalization company.In addition, in the Happiness business segment, Club Med, a subsidiary of FTG, is the global leader that offers exquisite “all-inclusive” holidays. Atlantis Sanya is the leading integrated high-end tourism destination in China, helping to usher Hainan tourism into the 3.0 era. Laomiao Gold, a subsidiary of Yuyuan, is a China time-honored brand and a nationally renowned jewelry brand. These industry-leading companies and products have helped Fosun consolidate its leading position in related sectors.For Fosun, steady and profitable growth is driven by two factors: innovation and globalization.Amid the current domestic economic “involution”, “going global” has become a “must-do” for businesses. Fosun, which began its globalization journey as early as 2007, has become one of the benchmark global companies rooted in China. It has also established a profound industrial presence in more than 35 countries and regions worldwide.During its 17-year globalization journey, Fosun has achieved many successful projects and faced various challenges. Most importantly, this experience has allowed Fosun to develop globalization capabilities that rare among domestic companies. In addition, it has allowed Fosun to connect different markets, industries, and resources globally, achieving global presence, operations and development, while continuously enhancing its global operation capabilities.This is further illustrated by the following data, the Group’s overseas revenue for the first half of 2024 reached RMB45.87 billion, representing a year-on-year increase of 4%, and accounting for 47% of total revenue. Nearly half of the revenue came from overseas, which is rare among Chinese companies.More importantly, Fosun has actively driven the empowerment and synergy of its corporate ecosystem in the course of globalization. Its domestic and overseas member companies have made significant progress in global research and development (R&D), business expansion, operations, and investment and financing.For example, HANQUYOU, independently developed by Fosun’s subsidiary Shanghai Henlius, received marketing approval from the United States (U.S.) Food and Drug Administration (FDA), making it a “Chinese” monoclonal antibody biosimilar approved in China, the European Union (EU), and the U.S. HANLIKANG, China’s first biosimilar, received marketing approval from the Peruvian General Directorate of Medicines, Supplies and Drugs (DIGEMID) in Peru, making it the third self-developed drug of Shanghai Henlius to be approved for overseas marketing after HANQUYOU and HANSIZHUANG.Moreover, Club Med, a subsidiary of FTG that operates 67 resorts worldwide, achieved a record-high business volume of RMB8.89 billion in the first half of 2024, representing a year-on-year increase of 10.3%. Club Med’s business in the Europe, Middle East and Africa (EMEA) region and the Americas continued to grow, and its business in Asia-Pacific region recovered significantly. In May 2024, Club Med signed an agreement in Oman for the launch of its first resort in the Middle East.Fosun Insurance Portugal, which began its operations in Portugal, has been actively expanding into overseas markets. In the first half of 2024, it achieved business growth domestically and internationally. The contribution from overseas markets further increased, with international business recording premiums of EUR885 million, accounting for over 30% of the total premiums; the net profit of international business was approximately EUR51 million, accounting for over 40%.Easun Technology, a global leading automation and digitalization company under Fosun, has also been advancing its overseas expansion. In the first half of 2024, it achieved new overseas orders of RMB3.99 billion, with a significant increase in orders from the U.S. market, reaching RMB750 million, more than doubling year-on-year.Innovation is also a core competence that Fosun has accumulated over a long period of time and has always adhered to. During the reporting period, Fosun invested a total of RMB3.5 billion to deepen its technological and innovation capabilities. Its integrated innovation model under a global vision has become more mature, resulting in a number of ground-breaking achievements that are steadily generating profits and driving Fosun’s growth.In terms of innovative drug R&D, Fosun Pharma has 4 products with a total of 9 indications were approved for marketing; 4 products with a total of 9 indications had entered the pre-launch approval stage/key clinical stage; and 9 products (by indication) have been approved to conduct clinical trials. Shanghai Henlius’ independently developed and manufactured innovative biologics continue to make breakthroughs. The world’s first anti-PD-1 monoclonal antibody for the first-line treatment of small cell lung cancer (SCLC), HANSIZHUANG, has been approved for 4 indications, benefiting over 75,000 patients. It has also been out-licensed to over 70 countries and regions, including the U.S., Europe, Southeast Asia, the Middle East, and North Africa. In addition, the new indication for SUKEXIN, a new generation of oral thrombopoietin receptor agonist (TPO-RA), has been approved by the National Medical Products Administration (NMPA).New progress has also been made in the deployment of cutting-edge medical devices and innovative therapies. In June 2024, Intuitive Fosun Headquarters Industrial Base was inaugurated in Shanghai. It is the largest integrated R&D, production and training base of Intuitive Surgical in the Asia-Pacific region, significantly accelerating the localization of the da Vinci surgical robot. Intuitive Fosun’s Ion robotic bronchoscopy was approved by the NMPA in March this year and was launched in July 2024.“Asset-light operations” taking shape, poised for revaluationBenefitting from the strong support in its business operations, Fosun’s financials have also continued to improve. During the reporting period, Fosun continuously optimized its asset portfolio, continuously reduced leverage, and maintained a sound financial position. As of 30 June 2024, the Group’s adjusted total debt-to-capital ratio was 50.2%, maintaining a downward trend since 2020. Adjusted NAV was HK$17.4 per share, indicating that Fosun International’s current share price is significantly undervalued.Meanwhile, Fosun has actively strengthened its financial cushion and maintained ample cash reserves. As of 30 June 2024, Fosun International’s cash and bank balances and term deposits reached RMB109.55 billion, representing an increase of RMB17.1 billion compared to the end of 2023. In the 17 years since its listing, Fosun has accumulatively paid out HK$25.6 billion in dividends, with the dividend payout ratio gradually increasing to over 20% in the past five years.In June 2024, the international rating agency S&P fully recognized the effectiveness of Fosun’s financial strategy and affirmed its rating outlook as “stable”.While achieving stable profits through ongoing innovation and globalization, Fosun has also responded to the new market environment by streamlining its business. It has progressively exited some non-core industries and has actively advanced its asset-light strategy, which is now taking shape.In May 2024, Fosun sold all of its 99.74% stake in the German private bank HAL, which attracted market attention. After the completion of the transaction, Fosun will no longer hold any shares in HAL, but will retain the HAFS asset servicing business, managing approximately EUR100 billion in assets in an asset-light operation model.In the tourism sector, Fosun’s asset-light operation model has achieved remarkable results, with IPs such as Club Med, Atlantis Sanya, and Taicang Alps becoming benchmarks in the domestic tourism industry. In the first half of 2024, 85% of Club Med resorts adopted a leasing and management model, with the proportion of self-owned resorts declining to 15%.In April 2024, the AMAZE Snow Mountain Camp, FTG’s new IP in Lijiang Club Med Resort, quickly became a hit after its opening, driving significant occupancy increases at the nearby Club Med Lijiang Resort and Joy Holiday Hotel Lijiang.In June 2024, FTG joined hands with the Taicang Municipal Government to build the phase II of Taicang Alps Resort, a one-stop ice and snow-themed urban tourist destination. The phase II project, with a total investment of over RMB5 billion, is funded by the Taicang Municipal Government and operated and managed by FTG. The successful operation of the Alps Snow Live has provided confidence and momentum for the phase II project, which is expected to set several world records in ski resorts.Fosun has also joined hands with partners to set up a number of industry funds to drive the future of advantageous industries. In March 2024, leveraging its leading advantages in biomedicine, Fosun Pharma joined hands with Shenzhen Guidance Fund and seven other investors to jointly establish a RMB5.0 billion biomedical industry fund, with all proceeds to be invested in biomedical, cells, genes, etc. Shanghai Fujian Equity Investment Fund Management, a subsidiary of Fosun Pharma, was selected through public selection process in Shenzhen to exclusively manage this fund. In April this year, the Shenzhen Municipal Government and Fosun signed a strategic cooperation framework agreement, both parties will further strengthen cooperation in areas such as biomedicine, cultural and sports tourism, and fashionable consumption.In addition, Fosun Capital, together with Wuhan Innovation Investment and Wuhan Fund, established a RMB3.0 billion industry fund with an initial scale of RMB1.1 billion in April 2024. This is the first batch of market-oriented fund invested by Hubei Province since the establishment of the RMB20.0 billion government guidance fund, mainly focusing on the four major sectors of new generation information technology, dual carbon, intelligent manufacturing, and consumption.Given the current market environment, it is expected that Fosun will continue to focus on asset-light operations, continuously expand its “circle of friends”, strengthen in-depth cooperation with all parties, and achieve win-win results through complementing each other’s advantages.Market analysts believe that Fosun has achieved sustained and stable profits leveraging its core strategies of innovation and globalization. In addition, by exiting non-core assets, pursuing asset-light operations, and continuously reducing debt, Fosun has maintained robust financial health, paving the way for a potential market revaluation.Guo Guangchang believes that in the future, investors will place greater emphasis on the growth of core industries and the stability of cash flow. “One-off asset sales are only short-term solutions. The growth of core businesses is crucial for a company to achieve stable profits.” Fosun aims to build a consumer group centered on core industries, ensuring more predictable business development and profits. At both the group level and within each business unit, Fosun is committed to creating value for its customers and investors that is manageable in terms of risk and promotes steady growth. Copyright 2024 ACN Newswire via SeaPRwire.com.
More
Rockbird Media Triumphs with Inaugural Vietnam Edition of the Retail and E-Commerce Summit Asia ACN Newswire

Rockbird Media Triumphs with Inaugural Vietnam Edition of the Retail and E-Commerce Summit Asia

HO CHI MINH CITY, VIETNAM, Aug 30, 2024 - (ACN Newswire via SeaPRwire.com) - The much-anticipated Retail & E-Commerce Summit Asia (RESA) 2024 made history as it concluded its inaugural event in Vietnam, following its remarkable success across other countries in Southeast Asia. Held on August 22, 2024, at Mai House, Ho Chi Minh City, this landmark summit welcomed retail and e-commerce leaders seeking to capitalize on digital expansion.Attendees, including C-level executives, industry innovators, and emerging entrepreneurs, engaged in a day of transformative discussions and networking opportunities that set the stage for the future of digital retail growth.With the theme "Retail Revolution: Solidifying Growth Through Digital Expansion," the event offered unparalleled insights into the dynamic intersection of retail and technology in burgeoning markets such as Vietnam. Participants gained access to cutting-edge strategies and exclusive content aimed at navigating the complexities of today’s e-commerce landscape, ensuring they were left equipped with actionable knowledge and essential connections.On the valuable insights from the first-ever RESA Vietnam, it’s all about personalization for Le Huynh Phuong Thuc, Managing Director of Guardian Vietnam and one of the event speakers. “The more personalization that we can have, the more we understand about the customer and have the customized offers to the customers at the right timing, with the right value, with the right products.”With Vietnam's market experiencing robust growth, fueled by the potential of digital expansion and increasing foreign investment in retail and e-commerce, RESA offered a prime opportunity to enhance industry knowledge and network. The summit's unique format fostered a collaborative environment where industry leaders could exchange ideas and explore future opportunities.“Given this is the first time that you organized an event here, I say it's impressive,” Huyen Trinh-Thanh, Co-Founder and CGO of Piktina, and another speaker, noted of the event. “I enjoyed the quality of the discussions today. I've got to meet a lot of good people as well as C-suite or C-level people, all of the decision-makers are in the room. The discussions were thoughtful and insightful.”For more information, you can visit: https://rockbirdmedia.comAbout rockbird mediaRockbird media is an international business media company that produces B2B events and offers business solutions.Whether it is through online media and content, must-have business intelligence and analytics, effective networking, and partnering solutions, we help businesses and professionals learn more about the latest trends, and know more about their customers, peers, and competition, to make that decision that allows them to grow.Media contact:annjubelle@rockbirdmedia.com Copyright 2024 ACN Newswire via SeaPRwire.com.
More

Hua Medicine Announces 2024 Interim Results

- Dorzagliatin (trade name: HuaTangNing, world's first dual-acting glucokinase activator (GKA), successfully entered China’s National Reimbursement Drug List for Basic Medical Insurance, Work-related Injury Insurance and Maternity Insurance (the “NRDL”) at the end of 2023. Hua Medicine worked with sales promotion partner Bayer Healthcare Company Limited (“Bayer”) and 80 Tier 1 distributors to begin the pharmaceutical market entry in 31 municipalities and provinces in China.- The new NRDL became effective on January 1, 2024. In the first half of 2024, the sales volume of dorzagliatin increased significantly. As of June 30, 2024, sales of HuaTangNing reached 846,000 packs with a sales revenue of RMB102.7 million. The sales revenue increased by 46%, compared with the six months ended June 30, 2023.- Dorzagliatin experienced a fast entry into hospitals, especially in Shanghai, Beijing, Tianjin where the government policies support market entry for novel new drugs. By the end of June 30, 2024, dorzagliatin was prescribed in over 2,100 hospitals and over 2,900 pharmacies. Dorzagliatin was sold principally through hospitals (approximately 72% of total sales), with the remainder of sales through pharmacies (20%) and internet drug stores (8%).- Gross profit in the first half of 2024 is RMB47.8 million, representing a gross profit margin of 46.5%. Bank balances and cash position increased by 51.9% to approximately RMB1,338.8 million for the six months ended June 30, 2024, compared with the six months ended June 30, 2023.- Dorzagliatin manufacturing capacity continues to expand, with the expectation to reach 3 million packs in 2024. New processes for larger capacity have been established with our partners and are under regulatory review for production permit.- Post marketing clinical studies proceeded at an accelerated rate, in which HMM0601 enrolled 1,368 patients and HMM0701 enrolled 102 patients. HMM0601 is designed to evaluate the long-term safety of dorzagliatin by collecting 1-year clinical safety data in 2,000 T2D patients and HMM0701 is a prospective real-world study to explore dorzagliatin’s clinical beneficial effects on the improvement of glucose homeostasis, cognitive function and diabetes remission. A good drug safety profile for dorzagliatin has been observed since its commercial launch in October 2022 – a time span of over 20 months and approximately 100,000 patient exposure.- Two Mendelian randomization studies conducted by our collaborating Hong Kong-based clinical investigators, and published in Cardiovascular Diabetology showed that glucokinase activation can lead to long term benefits in reduction of risks in cardiovascular diseases and dyslipidaemia. New clinical indications shall be further explored with our commercialization partner.HONG KONG, Aug 30, 2024 - (ACN Newswire via SeaPRwire.com) - Hua Medicine (the "Company", HKEx: 2552) today announces the unaudited consolidated results of the Company and its subsidiaries for the six months ended June 30, 2024 (the "Reporting Period"), and the Company’s business progress for the first half of the year and business outlook.Dr. Li Chen, the founder and CEO of Hua Medicine, said, “The first half of 2024 marks a milestone for the commercialization efforts of Hua Medicine. Dorzagliatin's successful inclusion in China’s National Reimbursement Drug List has significantly improved patient accessibility and affordability. Against the backdrop of comprehensive support from the national and local governments for the development of the biopharmaceutical industry, and with the joint efforts of the Company, commercial partners, and production partners, the production capacity of dorzagliatin is rapidly increasing, accelerating its entry into hospitals and pharmacies nationwide to benefit more patients. With the continued growth in the number of users, the safety of dorzagliatin has been well validated, and its economic and social benefits have also greatly increased, instilling confidence in the Company's future development. Through sales expansion and operational optimization, we hope to achieve profitability for the Company by 2025. Currently, Hua Medicine is also conducting basic and clinical research on dorzagliatin globally, aiming to continuously expand its indications and target populations, explore new disease areas, and promote human health and well-being.”Progress of Clinical Research and Company Operations- During the first reporting period under the NRDL, dorzagliatin experienced a fast entry into hospital and pharmacies, especially in Shanghai, Beijing, Tianjin where the government policies support market entry for novel new drugs. The number of hospitals prescribing dorzagliatin exceeded 2,100 in the first half of 2024.- Revenue of dorzagliatin reached RMB102.7 million in the first half of 2024 and is expected to continue to grow in the second half of 2024. As we build off our new foundation under the NRDL, we plan to leverage our well-established partnerships to enhance the dorzagliatin manufacturing process, which is expected to lead to efficiencies, expanded capacity and reduction of cost of goods.- We continued our post marketing clinical studies at approximately 80 hospitals to better understand the benefits dorzagliatin provides to patients with Type 2 diabetes and T2D complications, such as memory loss and diabetes kidney disease. Through our collaboration with our clinical research partners in Hong Kong, we have discovered that glucokinase (GK) activation may bring the benefits of reduction of risks in cardiovascular disease, and dyslipidemia. These results (applying the Mendelian Randomization (MR) methodology) certainly expand our understanding of the benefits of GK activation through dorzagliatin and for uncovering new indications of dorzagliatin in the future. Mendelian Randomization (MR) is a statistical method that uses genetic variants to investigate the causal effects of exposures (e.g., treatments) on outcomes (e.g., diseases). Its unique advantage lies in its reduced susceptibility to confounding and time-related biases compared with observational studies, which is achieved by leveraging the random allocation of genetic variants at conception. In evidence-based medicine, the credibility of evidence from MR is considered to be among the highest, second only to that of randomized controlled trials.- We have advanced our post-marketing real world evidence (RWE) studies HMM0601 and HMM0701 in T2D patients in China, and HMM0123 in Hong Kong, China. In these studies, we are collecting evidence in medical practices for optimization of glucose homeostasis either through dorzagliatin alone or in combination with standard care T2D medications such as metformin, DPP-IV inhibitors, SGLT-2 inhibitors, GLP-1RA and insulin. These results create new evidence for dorzagliatin in the expansion of its indication in diabetes prevention and remission.- We are continuing our drug development pipeline with focus on the fixed dose combination (FDC) of new drug candidates. The new drug Dorzagliatin-Metformin FDC entered manufacturing process validation and our plan is to launch this new medicine for Type 2 diabetes in 2028. Additional new FDC drugs with dorzagliatin will be developed for T2D patients, tailored specifically to address T2D patients with associated complications such as obesity and diabetes kidney disease.- To further leverage the unique advantage of dorzagliatin in restoring GLP-1 secretion in patients with diabetes and obesity, Hua Medicine initiated its Phase I study in the United States with our 2nd generation GKA. The trial has been proceeding smoothly and has already completed dose escalation in three cohorts of T2D patients in the United States. The topline data is expected to be available in the fourth quarter of 2024, supporting future drug development.- At the American Diabetes Association (ADA) Annual Meeting 2024, Hua Medicine reported new scientific data supporting the combination of dorzagliatin with a SGLT-2 inhibitor which led to improvement in glycaemic control. Combination of dorzagliatin with chronic kidney disease (CKD) medicine, such as SGLT-2 inhibitor, empagliflozin, in mid to late stage diabetes kidney disease patients, offers new opportunity to expand dorzagliatin’s indication.- We are exploring more drug repurposing opportunities for dorzagliatin using MR framework, such as renal diseases, neuropathy related diseases, eye related diseases, cognitive disorders, and cancers. Animal studies shall be further performed to validate the promising findings.- We are continuing to optimize our protein allosteric modulation technology (PAMT) and expansion from positive allosteric modulator (PAM), such as GK positive allosteric modulator dorzagliatin, to negative allosteric modulator (NAM) in kinase and G-protein-coupled receptors (GPCR) proteins. The GK NAM program advanced to the pre-clinical candidate (PCC) selection stage and final optimization of the PCC to clinical candidate for congenital hyperinsulinism (CHI), and potentially for dyslipidaemia. We continue to advance mGLUR5 NAM program for its clinical potential in Parkinson’s disease (PDLID), Fragile X syndrome (FXS), and drug addiction.Financial highlightsAs of June 30, 2024,- Bank balances and cash position was approximately RMB1,338.8 million.- Total revenue generated by the Company was approximately RMB102.7 million, reflecting sales of approximately 846,000 packs of HuaTangNing .- Total other income was approximately RMB55.1 million, of which approximately RMB47.8 million was attributable to the amortization of Bayer milestone income.- Total expenditures was approximately RMB245.9 million, of which approximately RMB119.8 million was attributable to research and development expenses.Forward-looking StatementThis article contains the statements regarding the future expectations, plans and prospects for Hua Medicine and the investigational product. The forward-looking statements made in this article relate only to the events or information as of the date on which the statements are made in this article. Except as required by law, we undertake no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events. You should read this article completely and with the understanding that our actual future results or performance may be materially different from what we expect as a result of various risks, uncertainties, or other legal requirements.About Hua MedicineHua Medicine is an innovative drug development and commercialization company based in Shanghai, China, with companies in the United States and Hong Kong. Hua Medicine focuses on developing novel therapies for patients with unmet medical needs worldwide. Based on global resources, Hua Medicine teams up with global high-calibre people to develop breakthrough technologies and products, which contribute to innovation in diabetes care. Hua Medicine's cornerstone product HuaTangNing (dorzagliatin tablets), targets the glucose sensor glucokinase, restores glucose sensitivity in T2D patients, and stabilizes imbalances in blood glucose levels in patients. HuaTangNing was approved by the National Medical Products Administration (NMPA) of China on September 30th, 2022. It can be used alone or in combination with metformin on hydrochloride-tolerated T2D patients. For patients with chronic kidney disease (CKD), no dose adjustment is required. It is an oral hypoglycemic drug that can be used for patients with Type 2 diabetes with varying degrees of renal function impairment (including end-stage renal impairment without dialysis). Hua Medicine partnered with Bayer, a leading global pharmaceutical company, to commercialize HuaTangNing in China, benefiting diabetic patients and their families.For more informationHua MedicineWebsite: www.huamedicine.comInvestorsE-mail: ir@huamedicine.comMediaE-mail: pr@huamedicine.comDisclaimerFor the accuracy and completeness of the context, references to information related to products launched in China, especially label or requirements, should follow the relevant documents approved by the Chinese regulatory authorities.The above information should not be interpreted as a recommendation or promotion of any drug or treatment regimen, nor should it substitute for the medical advice of any healthcare professional. Please consult a healthcare professional for any matters related to medical treatment. Copyright 2024 ACN Newswire via SeaPRwire.com.
More
InfoComm India 2024 to Feature 32 New Exhibitors and close to 30 Launches of Pro AV Technology, Products and Solutions ACN Newswire

InfoComm India 2024 to Feature 32 New Exhibitors and close to 30 Launches of Pro AV Technology, Products and Solutions

MUMBAI, INDIA, Aug 30, 2024 - (ACN Newswire via SeaPRwire.com) - The countdown is on! InfoComm India 2024, India’s premier professional audiovisual and integrated experience solutions event, opens its doors in just one week. For a decade, the show has delighted the region by showcasing cutting-edge technologies and ideas in all areas of Professional AudioVisual (Pro AV) technologies. The 2024 edition is gearing up for its largest showcase yet – featuring 250 exhibitors and brands, of which over 30 are first-time participants. Visitors can also look forward to experiencing nearly 30 new and first-to-debut products in India and Asia.InfoComm India will take place from 3-5 September at the Jio World Convention Centre (JWCC) in Mumbai, India. Tech innovators, professionals, and enthusiasts are welcome to preview the hundreds of products and solutions ahead of time as well as pre-register to obtain their show badge and also take advantage of the 45 sessions at the InfoComm India Summit 2024 and a host of networking and experiential activities.The tenth edition of India’s Premier Pro AV and Technology showcase expands beyond Pavilions 1 to 3 at JWCC, adding Jasmine Hall (at Level 3) for an even larger showcase of innovative solutions.Some of the featured and first-to-debut in Asia and India include:BENQ: Showcasing India’s No. 1 Google EDLA-certified Board Pro, BENQ presents robust educational tools for an enriched learning experience.CANON: Introducing Canon’s first ‘4K PTZ Remote Camera’ targeting at shooting and distribution of high-quality videos, with quick response in the remote operations, offering flexible operation in video production and broadcasting.AV MASTER TECHNOLOGY: Introducing Super Cue Intelligent PPT Clickers for all kinds of educational sessions or press conferences to deliver flawless presentations with precision control. Over 30 first-time exhibitors will also be demonstrating their innovations alongside established participants, adding vibrancy and dynamism to the showcase. They include:GENERATION AV: Headquartered in Singapore, representing major AV brands such as Optimal Audio, iMAGsystems, Sonance, James Loudspeaker for live events.INFONICS TECHNOLOGIES: India’s own “Leading LED Videowall Manufacturer”.NEOTOUCH: Chennai-based manufacturer, specializing in interactive flat panel with in-built WiFi and Bluetooth connectivity to enhance the productivity at schools and boardroom meetings.InfoComm India 2024 | Jasmine Hall opens earlier at 9.10am on opening day and set to feature even more emerging innovatorsInfoComm India 2024’s new expanded show floor at Jasmine Hall on Level 3 of JWCC will be a hub for networking, learning, and interactive activities. Jasmine Hall opens earlier at 9.10 am to welcome attendees to be part of the Opening Ceremony. Visitors are also invited to join a plethora of networking events within the Jasmine Hall, including:3 and 4 September, 9.30 am – the “Breakfast Networking Hours” hosted by InfoComm India and AVIXA leadership, offers a platform for industry peers to connect and mingle before the show opens.3 September, 5 pm – the “Welcome Networking Event” on opening day provides another opportunity for visitors from diverse sectors and background to build relationships.Visitors seeking a guided experience, and a curated list of products and solutions can sign up for the 3 September, New Tech Products & Solutions show floor tour. Slots are limited!Finally, no visit to InfoComm India 2024 would be complete without checking out the Multisensory Immersive Experience. Co-presented with MSS World + Studio Ocupus, this multisensory showcase at SB01, Jasmine Hall combines cutting-edge projections, interactive floors, and multi-channel surround sound to immerse visitors in the beauty and power of nature.InfoComm India 2024 | A plethora of networking, learning and interactive activities at the show ensures a meaningful and fruitful visit for professional attendees.To skip long queues at the show, register and secure show badge now.For full details on speaker and session lineup, exhibitors, products, registration, and remaining sponsorship opportunities, visit InfoComm India.To access more press information of InfoComm India 2024, please visit: Digital Press Office Kit For more information, please contact:Rest of the WorldAngie EngMarketing DirectorInfoCommAsia Pte Ltdangieeng@infocommasia.comIndiaSooraj DhawanDirectorFalcon Exhibitions Pvt Ltdsooraj@falcon-mail.com Copyright 2024 ACN Newswire via SeaPRwire.com.
More
Anson Resources Underground Injection Control Permit for the Green River Lithium Project Approved ACN Newswire

Anson Resources Underground Injection Control Permit for the Green River Lithium Project Approved

Anson Resources Achieves Key Permitting MilestoneHighlights:Anson has been granted an Underground Injection Control (UIC) application for Class V wells to dispose of the processed brine at its Green River Lithium Project,The Utah Department of Environmental Quality has granted the application after a public comment consideration,The disposal wells will be located on Blackstone Minerals purchased private property,Application is based on production of 10,000 Li2CO3 tons/annum,Application applies for the development of 4 disposal wells,Conditions for Class V disposal wells include:Brine must be returned to the same Formation it was extracted from, not necessarily from the same horizon as extraction (resulting in no dilution),Volume and geochemistry of disposed brine must be like that of extracted brine,These requirements are met using the Direct Lithium Extraction.NEWPORT BEACH, CA, Aug 30, 2024 - (ACN Newswire via SeaPRwire.com) - Anson Resources Limited (ASX:ASN) (Anson or the Company) through its 100% owned subsidiary Blackstone Mineral NV LLC is pleased to announce that its Underground Injection Control (UIC) application has been approved by the Utah Department of Environmental Quality, Division of Water Quality for its Green River Lithium Project (Project), in the Paradox Basin in south-eastern Utah, USA. The Division of Water Quality has granted the application after its review and consideration of public comments. This UIC application will enable Blackstone to re-inject the spent brine from its Direct Lithium Extraction (DLE) processing plant back into subsurface formations.Anson is planning to drill new disposal wells, at the time of construction of the production plant, for the injection and disposal of the spent brine from its lithium extraction process as part of the development of the project into production. Several historical plugged and abandoned oil and gas wells are in the area and intersected similar brine reservoirs and confirmed the existence of horizons that had been encountered in the Green River area which can be used as the disposal zones. Some of these wells have already been converted into disposal wells which indicates the ability for those horizons to absorb the waste brine.The disposal wells will be located on the private property recently purchased by Blackstone, see ASX Announcement 13 September 2023. When the lithium processing plant has reached its optimal production rate there will be four disposal wells in operation which have been included in the one application, see Figure 1.The spent brine will be pumped via the injection wells into the Paradox Reservoirs, at shallower horizons into the most permeable rock formations reducing the required pumping pressure.Archaeological, environmental and site surveys have been conducted over the proposed areas and these reports have already been submitted to the Utah Division of Oil, Gas and Mining (UDOGM) as part of the drilling application. These surveys, which showed no issues with the already disturbed site, were carried out over the proposed production site, extraction and disposal well locations and surrounding areas. Access to these sites will be via county roads that exit the I70 interstate and already developed roads in existence in the Blackstone property resulting in minimal disturbance.The UIC application was a detailed report and included:Maps of the Area of Review (AOR) - 2-mile radius surrounding the proposed disposal wells,Maps and cross sections of underground sources of drinking water (USDW),Maps and cross sections of local geologic lithology, structures, and hydrologic settings,Injection well construction plan and operational plan,Corrective action plan,Monitoring, recording and reporting plans,Plugging and abandonment,Financial Responsibility (reclamation).Anson's research into the surrounding historic wells has shown that test-work, such as core sampling and flow testing, has been carried out on some of the wells which was suitable for use in providing additional information for the application. Drill Stem Tests were also carried out through some of these intervals which provides information such as porosity and permeability which will assist in the determination of the horizons to be used for disposal.Executive Chairman and CEO Bruce Richardson commented, "This approval from the Government of the State of Utah demonstrates that Anson can continue to progress the project at Green River by following the regulatory process. Progress in the past 12 months at Green River has been much faster than that of the Paradox due to the ownership of the surface area and the support from the local and state government departments and representatives for which we are extremely grateful. The reinjection of the brine back into the geological formation from which it is originally extracted protects other minerals contained in the brine for future use. The Company continues to engage with the local community to ensure that the best options for the development of the project into production are selected. We look forward to an open dialogue with the community and government as the remaining permits are considered as we move closer to production."Positive ESG AspectsThe drill program is designed to have as little impact on the environment, social and recreational activities as possible within the drill location areas which is further increased by carrying out the program on private property. There will be minimal new ground disturbance as the drill pads will be located on flat ground in areas that have already been disturbed.The use of areas where there has already been ground disturbance is consistent with Anson's aim of developing a sustainable project and minimizing environmental impact.Conservation of Water AquifersThe exploration drilling program has been designed to ensure that there is no interaction between the surface waters and the supersaturated lithium brines with the well-being steel cased and cemented in place.The majority of the water-yielding rock units in the area are part of either an upper or lower hydrologic system. The two systems are separated by the impermeable salt beds of the Pennsylvanian Paradox Formation, which underlies the counties in the region (Weir, Maxwell & Zimmerman, 1983) which is further supported by the salinity values intersected in this "surface" drilling recently completed by Anson.Contact Info:William MazeHead of Investor Relationsinvestors@ansonresources.comSOURCE: Anson Resources Copyright 2024 ACN Newswire via SeaPRwire.com.
More

Baguio Green Group Announces 2024 Interim Results

HONG KONG, Aug 29, 2024 - (ACN Newswire via SeaPRwire.com) - Baguio Green Group Limited (‘‘Baguio’’ or the ‘‘Group’’, Stock Code: 01397.HK) is pleased to announce its unaudited interim results for the six months ended 30 June 2024 (the Period”).During the Period, the Group’s revenue amounted to approximately HK$1,291.1 million, representing an increase of approximately 16.6% as compared to the same period last year, mainly due to the continued increase in revenue in the cleaning segment together with the waste management and recycling segment. Profit for the Period amounted to approximately HK$25.8 million, representing an increase of approximately 18.5% as compared to the same period last year. The overall gross profit increased by approximately 12.4% to approximately HK$97.1 million.Business Overview and ProspectsIn the first half of 2024, new contracts awarded to the Group amounted to a total of HK$1.48 billion. As a result, the Group’s contracts on hand reached approximately HK$4.60 billion (as of 30 June 2024), representing an increase of approximately 3.8% from approximately HK$4.43 billion as of 31 December 2023, providing strong revenue growth in the second half of 2024 and subsequent years.The Group’s core business, cleaning services, recorded growth during the Period. Revenue from cleaning services increased by 20.1% to approximately HK$1,034.9 million, accounting for approximately 80.2% of the Group’s total revenue. Gross profit of the cleaning business increased by 7.6% to approximately HK$66.4 million, mainly due to the Group’s new cleaning service contracts with various HKSAR Government (the “Government”) departments and different institutions.The Group’s Government-related street cleaning services cover a total of seven districts, serving a population of approximately 2.8 million, marking Baguio’s leading position in the Hong Kong cleaning services market. The Group’s Government venue cleaning services for the Food and Environmental Hygiene Department cover seven districts in Hong Kong. In addition, the Group also provided Government market related cleaning services and leisure venues cleaning services, covering several districts in Hong Kong, as well as other cleaning sites such as hospitals, Government clinics, Hong Kong International Airport, schools, housing estates and private institutions, demonstrating that the Group’s professional services are widely recognised.Waste management and recycling business recorded growth in revenue during the Period which increased by approximately 7.4% to approximately HK$147.3 million, accounting for approximately 11.4% of the Group’s total revenue. Gross profit of the waste management and recycling business increased by approximately 60.7% to approximately HK$19.2 million, mainly due to the “Plastic Recycling Pilot Scheme” entered the harvest period and the related contracts with the Government increased the recycling spots and revenue. During the Period, the Group provided Government-related waste collection services to five districts, serving a population of approximately 1.6 million, and provided collection services for thousands of recycling spots (including plastic, glass bottles, metals, waste paper and food waste) across Hong Kong, and collection services for recycling bins in public places and schools. During the Period, the Group provided Baguio continued to provide plastic collection services for several districts under the Environment Protection Department (“EPD”) Plastic Recycling Pilot Scheme contract. Baguio also provides collection services for Recycling Stations of “GREEN@COMMUNITY”, introduced by the EPD and smart recycling machines, and other institutions in Hong Kong. In addition, the Group also provides the Government with glass bottles collection and management services and food waste collection services in several districts in Hong Kong.Regarding green technology business, the Group launched a smart recycling system through combination of a number of advanced smart digital technologies and Internet of Things technologies. Through a one-stop management and big data analytics platform, the Group can monitor the real-time situation of the recycling machines, and flexibly deploy transportation according to the amount of recyclables, reducing logistics costs and unnecessary carbon emissions. The Group currently provides smart recycling machines to the EPD and smart food waste recycling machines to private housing estates. At present, smart recycling machines and smart food waste recycling machines are now available in different places of Hong Kong, providing the public with a convenient recycling experience 24 hours a day, and helping to increase the overall recycling volume in Hong Kong. The Government is proactively offering financial aids for private housing estates to install food waste recycling machines through the Recycling Fund and the Environment and Conservation Fund. Under the expected market demand created by the strong advocacy of the Government, it is believed that the Group’s food waste recycling machines and related smart technology business will bring huge business opportunities. With the increasing market demand for smart recycling, the Group plans to seize the opportunity of smart city development, striving to expand the market share of smart recycling machines and smart food waste recycling machines.In addition, the Government is actively promoting the “Producer Responsibility Scheme on Plastic Beverage Containers and Beverage Cartons”, and plans to table the bill to the Legislative Council for scrutiny this year with a view to introducing it in 2025. Enshrining the principle of “Polluter Pays” and the vision of “Eco-responsibility”, the recycling rate of plastic beverage containers and beverage cartons is expected to have a significant increase. The scheme is expected to directly drive the growth of Baguio’s recycling business and create solid returns from our investment in recycling facilities which creates a strong entry barrier to the competition.In partnership with Jardine Engineering Corporation Limited, the Pilot Biochar Production Plant at the EcoPark in Tuen Mun was commenced trial operation during the Period. By converting yard waste into high-quality biochar with pyrolysis technology for various applications, the production plant effectively “turns waste into useful resources”.Hong Kong has made concerted effort to keep pace with international trends in the field of green and sustainable finance, accelerating its progress towards becoming an international green finance hub. To meet the needs of sustainable development, the Group has incorporated sustainability insights into its core businesses and operations and is committed to providing customers with one-stop and diversified green environmental services and sustainable procurement solutions. In the future, Baguio will invest more resources in personnel training and green procurement. Meanwhile, through the provision of waste audit services, the Group provides waste constituent data to help corporate customers understand the amount of generated waste that can be recycled and achieve sustainable development goals.As for the landscaping business, the Group provided landscaping services for the Kai Tak Sports Park, the Central and Western District Promenade and the Inclusive Park for Pets at Tsun Wen Road in Tuen Mun. In addition, the Group provides landscaping services for a wide range of clients, including large private residences, Government premises, schools, shopping malls, hotels, airports, Hong Kong Science Park, Hong Kong University of Science and Technology and Lingnan University, etc.For pest management business, the Group continued to provide pest management services in Wong Tai Sin and Tai Po districts during the Period. In addition, the Group provided termite control and monitoring services to 29 monuments under the Antiquities and Monuments Office and 24 temples under the Chinese Temples Committee respectively.The Government is developing the Northern Metropolis at full speed and a number of public housing estates are scheduled for completion in phases. In particular, intake of tenants at the public housing estates in northern Kwu Tung North and Fanling North New Development Area will commence progressively from 2026. The Northern Metropolis will provide about 500,000 new housing units after fully developed, which is believed to bring opportunities to the Group’s core businesses.Mr. Ng Wing Hong, Chairman of Baguio, commented, “The Government demonstrates a strong commitment to environmental agenda. Baguio’s core businesses are closely related to the livelihood of the general public and are not affected by the economic environment. Despite the presence of economic headwinds, the Group’s core business continues to demonstrate a growth trajectory.While the implementation of the Waste Charging was postponed during the Period, the Government has significantly increased its efforts to increase various types of recycling spots through recyclers. For example, the addition of night mobile food waste recycling spots to facilitate citizens’ recycling, with improvement in terms of quality and quantity, which directly brings growth impetus to the Group’s recycling business. Therefore, the postponement of Waste Charging has no adverse impact on the Group’s recycling business, and on the contrary, results in an increase in business. In the long run, waste reduction and recycling will help achieve the Government’s goal of “Zero Landfill”, and benefit the development of the Group’s recycling and green technology businesses.”Looking forward, the Group will continue to increase the market share of its core businesses and proactively engage in expansion in Hong Kong and beyond. Meanwhile, in line with the development of the Group, it will actively explore potential mergers and acquisitions, joint ventures or new business projects to accelerate future business growth and deliver substantial and long-term returns to shareholders.For details of the Group's 2024 interim results announcement, please visit the following website:http://www.baguio.com.hk/en-US/Investor%20Relations/Announcements%20and%20Notices- End -About Baguio Green GroupEstablished in 1980, Baguio Green Group (Stock code: 01397.HK) is one of Hong Kong’s largest integrated environmental services groups. It provides a full spectrum of professional services including professional cleaning, waste collection & recycling, waste management, green technology, organic fertilizer and animal feed production, horticulture & landscaping, and pest control. It serves a wide range of customers in various sectors including Government departments, statutory organizations and multinational corporations. Fully committed to ESG, the Group works relentlessly to advance sustainable development and create a cleaner, greener, healthier city. Copyright 2024 ACN Newswire via SeaPRwire.com.
More

CanSinoBIO Reports Outstanding H1 2024 Performance

HONG KONG, Aug 29, 2024 - (ACN Newswire via SeaPRwire.com) - CanSino Biologics Inc. (CanSinoBIO) today disclosed its performance report for the first half of 2024, with revenue reaching 303 million yuan, while losses were substantially reduced. The meningococcal conjugate vaccines demonstrated robust growth, particularly the Group ACYW135 Meningococcal Conjugate Vaccine (CRM197), known as MCV4 or Menhycia®. As the first quadrivalent meningococcal conjugate vaccine product in Asia, it not only fills the market gap, but also provides a better choice for the prevention of meningococcal disease in Chinese infants and young children. In the first half of 2024, CanSinoBIO's two meningococcal vaccines generated approximately 263 million yuan in revenue, marking a significant increase of around 18% compared to last year.In addition, CanSinoBIO is making strides in clinical trials for expanding the age group of MCV4, aiming to cover children aged four and above, as well as adults. This initiative seeks to broaden vaccination coverage to meet the needs of a wider population. Concurrently, the company is advancing the international market expansion of the MCV4, leveraging its successful overseas commercialization experience with its COVID-19 vaccine. CanSinoBIO is deepening collaborations with leading international research institutions, focusing on registration and commercialization in Southeast Asia, the Middle East, North Africa, and South America. It indicates that the company is accelerating the commercial layout in the global market.Moreover, the market expansion experiences and strategic partnerships will support to expand the reach of its PCV13i [13-valent pneumococcal conjugate vaccine (CRM197, TT Vector)] and DTcP (diphtheria, tetanus and acellular pertussis) components vaccine franchise in global markets. The company is also planning and preparing for WHO PQ certification, exploring the feasibility of international organizations. For global innovative products, CanSinoBIO will actively explore the possibility of accessing developed countries.In terms of commercialization strategy, CanSinoBIO has adopted an efficient and precise model, relying on its direct sales team and leveraging professional promoters to rapidly extend its marketing network to the county-level areas. The company adheres to a professional academic and customer-oriented approach, ensuring that products reach target groups through in-depth research and terminal services. This approach helps control sales expenses and achieves intensive operations. To date, CanSinoBIO has established a well-structured commercial operation center for both domestic and international markets. The MCV4 has been approved in 30 provinces in China, comprehensively opening up the domestic market. The successful commercialization of MCV4 has laid a solid foundation for the upcoming PCV13i, which is currently undergoing clinical and manufacturing site inspections as planned.CanSinoBIO has also made significant progress in cost reduction and efficiency improvement, with sales and administrative expenses decreasing by approximately 13% and 39% compared to the same period last year, respectively, reflecting ongoing improvements in operational efficiency.Overall, CanSinoBIO has integrated R&D, production, and commercialization, gradually transforming into a biopharmaceutical company. With the successful commercialization of MCV4 and the upcoming approval and launch of new products like PCV13i, CanSinoBIO's performance is expected to continue growing. The company’s management team is confident on the company's prospects and has demonstrated strong support through increasing shareholdings. Copyright 2024 ACN Newswire via SeaPRwire.com.
More
Watch & Clock Fair, Salon de TIME launch in September ACN Newswire

Watch & Clock Fair, Salon de TIME launch in September

- Kicking off the first round of autumn trade fairs, two watch fairs on 3-7 September will bring in 700+ global exhibitors- Themed “Be on Time”, fairs will showcase different styles of wristwatches, parts, accessories, machinery and equipment- Visitors can gain updates on the latest market information and trends through forums, seminars, watch parades and networking events- Salon de TIME will be fully open to the public for the first time to create a globally renowned annual event for the industryHONG KONG, Aug 29, 2024 - (ACN Newswire via SeaPRwire.com) - Organised by the Hong Kong Trade Development Council (HKTDC), Hong Kong Watch Manufacturers Association Ltd and The Federation of Hong Kong Watch Trades and Industries Ltd, the HKTDC Hong Kong Watch & Clock Fair and Salon de TIME will welcome more than 700 global exhibitors.Themed “Be on Time”, the fairs will feature different styles of wristwatches, parts, accessories, machinery and equipment to provide a one-stop sourcing platform. Under the hybrid EXHIBITION+ model, the physical fairs will run from 3 to 7 September at the Hong Kong Convention and Exhibition Centre (HKCEC), while exhibitors and buyers can meet online through the Click2Match smart business matching platform between 27 August to 14 September.For the first time, Salon de TIME will be fully open to the public for free admission. Sophia Chong, HKTDC Acting Executive Director, said: “This year, the Hong Kong Watch & Clock Fair and Salon de TIME will welcome more than 700 global exhibitors from 15 countries and regions, with new exhibitors from Belgium and Denmark as well as new brands from Greece, Türkiye and the United Kingdom. The two fairs will feature pavilions from Guangdong, Guangzhou, Taiwan as well as South Korea, which is returning after the pandemic, creating globally renowned annual fairs and business opportunities for the industry.”“To explore more new business opportunities, the HKTDC will bring about 80 buying missions from more than 50 countries and regions, including Finland, Germany, Norway, Poland, Russia, Spain, Switzerland, the United Kingdom in Europe; Brazil, Canada and the United States in the Americas; Japan, Singapore, South Korea, Thailand and Vietnam in Asia; and Israel and the United Arab Emirates in the Middle East,” she added.Salon de TIME presents famous global watch brandsSalon de TIME will host more than 130 internationally renowned watch brands and designer collections across five thematic zones: World Brand Piazza, Chic & Trendy, Craft Treasure, Renaissance Moment and Wearable Tech. Some exhibitors will also include retail offerings, allowing them to purchase watches on-site.Numerous styles of watches and accessories to cater to market trends and needsWith sustainability gaining traction in recent years, exhibitors at the two fairs have added a Green Solutions Suppliers label on their products to facilitate sourcing for buyers.Over 20 exhibitors will showcase sustainable watches, including:- German brand Lilienthal Berlin which has launched the world's first watch with a case made of recycled coffee grounds that won the New York Product Design Award, Green Product Award and iF Design Award; - Hong Kong exhibitor Gordon C. & Company Limited, which uses sustainable and biodegradable materials to manufacture watch cases and straps.Wearable tech with smart monitoring technologyThe Paris Olympics has prompted more interest in sport, fitness and wearable tech, providing opportunities for innovative watchmakers. This year’s Wearable Tech zone, led by the Federation of Hong Kong Watch Trades and Industries Ltd and more than 10 companies, will feature a complete industry supply chain, while showcasing software, accessories and the latest technology. Companies taking part include German brand Oskron, which has developed Link2Care, a new wireless monitoring solution for health data, and United Wealth Holdings Limited, which has developed a smart watch incorporating smart movement from Huawei that can also monitor health data.World Brand Piazza – luxury showcase of 10 international watch brandsWorld Brand Piazza, sponsored by Prince Jewellery & Watch for the 14th consecutive year, will present some exceptional luxury watches from 10 international brands: Baume & Mercier, Bovet, Corum, CVSTOS, DeWitt, Franck Muller, Kerbedanz, Montblanc, Parmigiani Fleurier and Sarcar.Watches include Golden Bridge Dragon from Swiss brand Corum. This wristwatch features an 18-carat gold dragon at its core, while the dragon’s eyes, tail and watch body are inlaid with diamonds, pearls and gemstones, respectively. The watch’s 18K gold rectangular movement is composed of more than 190 parts, reflecting its craftsmanship and HK$2.153 million price tag.The showcase also features Swiss brand Bovet’s 7-day Skeleton Tourbillon. The hands on the back side of the dial are reverse-fitted, so they can turn clockwise, using Bovet's proprietary and patented system. This watch is priced at HK$2.136 million.The two fairs will also feature watches and accessories with a range of styles and personalities that can match different market needs:- International Luxury Group returns with 15 international brands, such as Kenneth Cole, Police and Timberland. Among them, the American brand Kenneth Cole launched an automatic movement watch, which uses exquisite screws to embellish the internal structure of the dial and is equipped with a stainless-steel strap. - Hong Kong watchmaking brand ANPASSA features a wristwatch that can be combined with AR technology to present a unique Kowloon Walled City look. - Swiss brand ROMAGO is collaborating with Pokémon to launch a limited edition set of 250 watches. - A limited-edition tourbillon from Hong Kong’s Memorigin uses rare meteorites and a newly developed ultra-thin pearl tourbillon automatic movement to create its Explorer series watch, with a 39mm diameter and a thickness of just 9.9mm.- Swiss classic brand Solvil et Titus presents its Barista Collection of watches with exquisite design and retro style. The barrel-shaped watch body is equipped with an arched glass surface, reflecting the brand's belief that strong emotions brew over time. - Present, a watch and jewellery brand with oriental characteristics, is committed to bringing traditional craftsmanship and culture into the present, with its On the Love of Lotus concept.Unique craftsmanship from European watchmakersSwiss Independent Watchmaking Pavilion (SIWP) and Francéclat are returning this year, presenting 17 international brands. These include:- Pilo & Co Genève, founded by independent Swiss watchmaker Amarildo Pilo. The company has launched Corleone Evoluzione Superleggera, a unique piece with a domed and bevelled sapphire crystal, an ultra-light alloy, a meteorite dial and automatic chronograph movement. - French brand Montignac will present its Marina Capsule series of diving watches, which are made in France and water-resistant to a depth of 200m. The watch body is equipped with a unidirectional bezel and luminous coating, which can track diving time and depth.Nine major zones for buyersThe Watch & Clock Fair is made up of nine zones. The Pageant of Eternity zone showcases high-end OEM and ODM watches, while other zones cover complete watches, pre-owned watches, clocks, machinery and equipment, OEM smart watches, packaging & display, parts and components and trade services.Forums and seminars explore industry trendsVisitors can also gain first-hand market information and updates on the latest industry trends through forums, seminars, watch parades and networking events.At the Hong Kong International Watch Forum on 3 September, global watch association representatives will provide an overview of global trade and industry trends with their insights and visions on reshaping the global watch industry towards sustainability.At the Asian Watch Conference on 4 September, global market research agency Euromonitor International (Hong Kong) will analyse the latest market developments around this year’s theme, “The Infinite Possibilities with Watches”. Mr Frank Chen, Sales Director of Module of Huawei Device BG, and Mr Pierre Burgun, CEO of Pierre Lannier, will discuss the prospects of health monitoring and innovative practices for wearable tech as well as the latest trends for stylish wristwatches.On 5 September, Dr James Chung-Wai Cheung, Research Assistant Professor and Member of Research Institute for Smart Ageing of The Hong Kong Polytechnic University, and Mr Michael Ertl, CEO and Founder of ME & Friends AG, and Mr Paul Anthony Yuen, Secretary General of The Federation of Hong Kong Watch Trades & Industries Ltd., will explore how age-forward technology can empower the ageing population to maintain independence and embrace a more connected, active lifestyle.In addition, the HKTDC, The Federation of Hong Kong Watch Trades & Industries Ltd and the Hong Kong Watch Manufacturers Association Ltd are jointly organising the 41st HK Watch & Clock Design Competition to cultivate a new generation of watch designers and technicians and to promote innovation and continued development in watch design.The competition has two categories – Go Beyond Innovation for the Open Group and Talent Moment for the Student Group. The Made-to-Sell Award is also newly added to recognise student entries with market potential. Artist Benjamin Yuen has been invited as a guest judge this year.Award-winning works and finalists will be exhibited during the fairs, while the award ceremony will be held on 7 September at The Dial in Hall 3FG of Salon de TIME.A variety of events, lucky draws and workshop for the publicAt Salon de TIME, Mr Carlos Koo, Founder of CK Engraving and Metal Engraving Artist, will demonstrate the art of watch engraving. Watch influencers Billy Chan and Ko Sir will reveal their views into generational mindsets and offer insights on investing in luxury timepieces respectively.Mr Gary Ching, Founder of ANPASSA, will host a workshop titled “Watchmaking 101 Craft Your Own Timepiece”. A series of product launches and watch parades will be featured with celebrities, including table tennis players Doo Hoi-kem and Wong Chun-ting who just represented Hong Kong in the Paris Olympics, Hong Kong singer Aka Chio, YouTuber Jeffrey Fok and more.Visitors can also participate in lucky draws and join Smart Bidding to bid on their desired watches starting at a 90% discount off the retail price.In addition, Asia’s premier fashion event CENTRESTAGE will be held from 4 to 7 September at the HKCEC, showcasing designer brands from around the world. Visitors can view the latest products from more than 380 watch and fashion brands at the same venue.Export performance, Hong Kong watches and clocks:Q2, 2024Q1, 2024Change per quarter41.334.3+7Retail sales, Hong Kong watches and clocks*:20232022Change per yearHK$32.5 billionHK$25.6 billion+27%*Data from EuromonitorPhoto download: https://bit.ly/3MoUWCZThe HKTDC Hong Kong Watch & Clock Fair and Salon de TIME take place on 3-7 September at the Hong Kong Convention and Exhibition Centre. Introducing fair highlights at a press conference are Sophia Chong, HKTDC Acting Executive Director (4th from left), Eric Lai (3rd from left) and Edmond Ng (4th from right), Co-Chairmen, HKTDC Hong Kong Watch & Clock Fair Organising Committee 2024. Hong Kong exhibitor Gordon C. & Company Limited uses sustainable and biodegradable materials to manufacture watch cases and straps. German brand Oskron has developed Link2Care, a new wireless monitoring solution for health data. Sponsored by Prince Jewellery & Watch for the 14th consecutive year, World Brand Piazza presents rare watches from 10 international brands, including Corum’s Golden Bridge Dragon and BOVET’s 7-day Skeleton Tourbillon.Swiss classic brand Solvil et Titus presents its Barista Collection of watches with exquisite design and retro style. The barrel-shaped watch body is equipped with an arched glass surface, reflecting the brand's belief that strong emotions brew over time.Hong Kong watchmaking brand ANPASSA features a wristwatch that can be combined with AR technology to present a unique Kowloon Walled City look.Swiss brand ROMAGO collaborates with Pokémon to launch a limited edition set of 250 watches.Pilo & Co Genève, founded by independent Swiss watchmaker Amarildo Pilo, has launched Corleone Evoluzione Superleggera, a unique piece with a domed and bevelled sapphire crystal, an ultra-light alloy, a meteorite dial and automatic chronograph movement. The 41st HK Watch & Clock Design Competition has two categories – Go Beyond Innovation for the Open Group and Talent Moment for the Student Group. Award-winning works and finalists will be exhibited during the fairs.Dancers at the press conference showcase 27 selected timepieces. Websites:Hong Kong Watch & Clock Fair: https://www.hktdc.com/event/hkwatchfair/enSalon de TIME: https://www.hktdc.com/event/te/enMedia enquiriesPlease contact the HKTDC’s Communications & Public Affairs Department: Johnny TsuiTel: (852) 2584 4395Email : johnny.cy.tsui@hktdc.orgBubble MaTel: (852) 2584 4369Email : bubble.ma@hktdc.orgAbout HKTDCThe Hong Kong Trade Development Council (HKTDC) is a statutory body established in 1966 to promote, assist and develop Hong Kong's trade. With 50 offices globally, including 13 in Mainland China, the HKTDC promotes Hong Kong as a two-way global investment and business hub. The HKTDC organises international exhibitions, conferences and business missions to create business opportunities for companies, particularly small and medium-sized enterprises (SMEs), in the mainland and international markets. The HKTDC also provides up-to-date market insights and product information via research reports and digital news channels. For more information, please visit: www.hktdc.com/aboutus. Copyright 2024 ACN Newswire via SeaPRwire.com.
More

Noah Holdings Announces $50M Share Repurchase, Signaling Confidence in Overseas Growth

HONG KONG, Aug 29, 2024 - (ACN Newswire via SeaPRwire.com) - Noah Holdings Limited ("Noah" or the "Company") (NYSE: NOAH and HKEX: 6686), a leading and pioneer wealth management service provider offering comprehensive one-stop advisory services on global investment and asset allocation primarily for Mandarin-speaking high-net-worth investors, today announced its unaudited financial results for the second quarter of 2024.Noah recorded total net revenue of RMB 616 million in the second quarter of 2024. The wealth management business generated net revenues of RMB 416 million, while the asset management business reported net revenues of RMB 192 million.Strategically Overseas Expansion and Comprehensive investment SolutionsNoah’s overseas expansion is gaining momentum as client demand for global asset allocation strengthens, with overseas net revenue contribution increasing to 46.3% in the first half of 2024 and asset under management increasing 14.1% year-over-year during the quarter. Noah also raised US$ 338 million for overseas private equity, private credit, and other primary market funds year-to-date, a significant 40.2% year-over-year increase.Income from operations was RMB 134 million, an increase of 10.3% sequentially, with an operating margin of 21.8%, an increase from 18.7% in the first quarter of 2024. These results directly reflect the early success of Noah’s strategic transformation as it implements effective cost control measures, restructures its domestic business, and accelerates its expansion overseas."The pace of our overseas expansion is gaining momentum," said Zhe Yin, the Chief Executive Officer of Noah Holdings. "Our team of overseas relationship managers directly supporting this expansion grew 101.8% year-over-year and 24.2% sequentially during the quarter. While we are still in the relatively early stages of our overseas expansion, these results reflect the direction we are headed in going forward.”“Domestically, we are focused on stabilizing operations by streamlining our branch network to reduce overhead costs and adjusting our client service model to comply with evolving regulatory requirements by separating relationship and business development managers into different independent business units. While these initiatives may temporarily impact business activity over the next few quarters, they will ensure our ability to effectively and compliantly serve clients with a comprehensive portfolio of products in the long term. I am pleased with the progress we have made this quarter in expanding overseas, and confident in both our long-term growth potential and ability to consistently generate returns for shareholders."As of June 30, 2024, the number of overseas registered clients increased by 6.7% sequentially 23.0% year-over-year to 16,786, further reflecting the growing demand for overseas asset allocation. Notably, the number of overseas diamond and black card clients saw an even more substantial year-on-year increase of 14.2%.The Company also observed a shift in product preferences, a trend that aligns with the forward-looking strategies outlined in Noah's Chief Investment Office’s (CIO) house view. Interest in investment products increased substantially as a result of expectations for a potential Federal Reserve rate cut during the second half of the year. Known for its expertise and ability to offer clients alternative investments on a global basis, Noah is uniquely positioned to capitalize on this opportunity to grow its USD AUA.As of June 30, 2024, Noah’s overseas relationship manager team grew to 113, a 24.2% increase sequentially. This expansion reflects Noah’s commitment to building a robust presence in key international financial hubs, and enhances its ability to serve high-net-worth clients with comprehensive global investment solutions.Prioritizing Shareholder Interests and Delivering Sustained ReturnsAs part of its commitment to enhancing shareholder returns, the board of directors of the company authorized a share repurchase program under which the Company may repurchase up to US$50 million of its American depositary shares or ordinary shares, effective immediately. The authorized term for carrying out this share repurchase program is two years.Noah announced in November 2023 that a new capital management and shareholder return policy (the “Policy”) had been adopted, pursuant to which up to 50% the Company's non-GAAP net income attributable to shareholders of the preceding financial year will be allocated to a Corporate Actions Budget which will serve various purposes, including dividend distribution and share repurchases. The share repurchase program announced on August 29 2024 does not form a part of the Corporate Actions Budget under the Policy. The Corporate Actions Budget based on Noah’s financial performance in 2024 is expected to be determined and announced alongside the Company’s earnings results for the fourth quarter and full year ending on December 31, 2024.Ms. Jingbo Wang, co-founder and chairwoman of Noah, commented, “This share repurchase program, along with the dividend payout we just completed, reflects our unwavering commitment to prioritizing shareholder interests and delivering sustained returns. While China’s wealth management industry is navigating a challenging period and undergoing a transition, we remain confident in Noah’s unique advantages stemming from our deep understanding of Mandarin-speaking high-net-worth individuals’ (HNWI) needs and our ability to deliver products and services to this still-growing client base. We are one of a few independent firms that maintains access, through years of investor education, to a large group of qualified individual investors who continue to seek professional services.”“As such, we believe that our stock is deeply undervalued and does not reflect our growth prospects, robust balance sheet and cash reserves, or the special bond we have formed with the Mandarin-speaking HNWIs globally. We value both our long-term and new shareholders and are committed to sharing our success with them through more proactive capital allocation policies moving forward.”Strengthening Commitment to ESG PrinciplesIn the first half of 2024, Noah published its 10th Annual environmental, social, and governance (ESG) report, highlighting its decade-long commitment to corporate responsibility and sustainable practices. Additionally, Gopher Asset Management, Noah's asset management arm, also joined the latest Nature Responsible Management initiative, Spring, announced by Principles for Responsible Investment (PRI) in 2024, reinforcing its role in driving responsible investment practices in order to halt and reverse biodiversity loss by 2030.By aligning with the PRI, Noah reaffirms its commitment to integrating ESG factors into its investment processes, fostering sustainable and responsible investment practices that benefit all stakeholders.Noah continues to adapt and evolve amidst a challenging market environment. The Company’s strategic initiatives, focused on global expansion, technological innovation, and sustainable practices, are beginning to yield tangible results, laying a strong foundation for continued success in the years to come. Copyright 2024 ACN Newswire via SeaPRwire.com.
More
Reitar Logtech Holdings Limited (RITR) Successfully Listed on Nasdaq ACN Newswire

Reitar Logtech Holdings Limited (RITR) Successfully Listed on Nasdaq

HONG KONG, Aug 29, 2024 - (ACN Newswire via SeaPRwire.com) - Reitar Logtech Holdings Limited ("Reitar Logtech") (NASDAQ: RITR) has officially listed on the Nasdaq stock market on August 23, 2024. This marks an important milestone in the company's internationalization, also signifies Reitar Logtech's commitment to driving the formation of smart logistics ecosystem, injecting new momentum into the industry.Founded in 2015, Reitar Logtech provides end-to-end logistics solutions by integrating real estate, logistics operations, and innovative technologies through two main segments:1. Asset management and consulting services - They source and develop logistics properties, enhance asset value through technology, and connect with suitable logistics operators.2. Construction management and engineering design - They provide project management services for logistics property development.Reitar Logtech's one-stop model allows them to deeply understand customer needs, provide tailored solutions, lower operating costs, and optimize overall logistics operations. As a pioneer in the PLT (property + logistics technology) space in Hong Kong with over 20 years of industry expertise and strong relationships with key players.The company serves both logistics operators (3PLs) and capital partners investing in logistics real estate projects. Reitar Logtech help 3PLs with property procurement, licensing, and strategic planning. The company help capital partners to source, develop, and manage logistics assets to maximize value. Reitar Logtech's integrated approach and deep industry knowledge are their key competitive advantages in the concentrated Hong Kong logistics services market.Reitar Logtech raised funds through its initial public offering (IPO) to accelerate product R&D, expand its global business footprint, and continuously optimize service quality. Going forward, Reitar Logtech will strive to consolidate its leadership position in the smart logistics field, partnering with global partners to drive the digital transformation of the supply chain, and lead the smart logistics industry into a new era of development, creating greater value for customers. Copyright 2024 ACN Newswire via SeaPRwire.com.
More

Cirrus Aircraft (2507.HK) Announces 2024 Interim Results

Results Highlights for the Six Months Ended June 30, 2024:- Revenue reached to approximately US$475.4 million, grew by 11.6% YoY- Gross Profit amounted to approximately US$163 million and gross profit margin was 34.4%- Profit grew significantly by 23.6% to approximately US$35.6 million- In the first half of 2024, the Company brought to market the 7th generation (G7) of the SR2X Series, which has been the best-selling single-engine piston model aircraft in the world for the last 22 consecutive years.- Net orders increased for both the SR2X and Vision Jet combined for the six months ended June 30, 2024 by a total of 107 units from 255 for the six months ending June 30, 2023 to 362 for the six months ending June 30, 2024.HONG KONG, Aug 29, 2024 - (ACN Newswire via SeaPRwire.com) - Cirrus Aircraft Limited (“Cirrus Aircraft” or “Company”) and its subsidiaries (together, the “Group”)( 2507.HK) announces the unaudited consolidated results for the six months ended June 30 2024 (the “Reporting Period”).During the Reporting Period, revenue of the Group grew by 11.6% to US$475.4 million, as compared with US$426.0 million for the same prior year period. Gross profit increased by 10.0% to US$163.4 million as compared with US$14.8 million for the same prior year period. Profit for the Reporting Period significantly increased by 23.6% from US$28.8 million for the same prior year period to US$35.6 million. It is primarily due to increased aircraft deliveries, increased pricing on the aircraft, and better mix of revenue generated from Cirrus Services and Other towards its services with higher margin.The leading aircraft manufacturer in the global personal aviation marketSince the inception in 1984 in Wisconsin, United States, Cirrus Aircraft is committed to design, develop, manufacture, and sell premium aircraft recognized across the personal aviation industry, which incorporate innovations in safety, technology, connectivity, performance, and comfort. The Company’s two aircraft product lines, the SR2X Series and the Vision Jet, have successfully set the industry standard for owner-piloted aircraft and are currently certified and validated in more than 60 countries with cumulative deliveries of over 9,700 SR2X Series aircraft and over 500 Vision Jet aircraft worldwide as of the June 30, 2024.As part of its wide-ranging product offering strategy, the Company’s SR2X Series consists of an entry level aircraft, the SR20, as well as the SR22 and SR22T, both of which offer increasing levels of performance and capabilities addressing different customer needs and preferences for a single-engine piston aircraft. SR2X Series aircraft can typically carry up to four adults and one child. The Vision Jet targets a different and more premium segment of the personal aviation market and offers significantly enhanced performance, capabilities and specifications at a higher price point. The Vision Jet is also designed for owners to fly at jet speed without requiring support from a full-time pilot or flight department. The Vision Jet can typically carry up to five adults and two children. With the launch of the G7 line and continuous upgrade of product portfolio, it will sustain the growth of the business and continue to provide a premium experience for the customers.In the first half of 2024, Cirrus Aircraft delivered 20 more aircraft and the average sales prices (“ASP”) of all deliveries steady increased as compared to the same period in 2023. The average sales price of the SR2X aircraft deliveries was approximately US$1.04 million compared to US$0.99 million in the same period in 2023. The average sales price of the Vision Jet aircraft deliveries was US$3.33 million compared to US$3.08 million in the same period in 2023. At the same time, net orders increased for both the SR2X and Vision Jet combined for the six months ended June 30, 2024 by a total of 107 units from 255 for the six months ending June 30, 2023 to 362 for the six months ending June 30, 2024. This increase is partly attributable to the launch of the G7 line as well as the continuation of the product ladder between the two product lines and the growing ecosystem around the ownership experience. The significantly increased net orders recorded during the Reporting Period will bring a great momentum for the steady growth of the Company.Outlook and Future PlanIn the future, Cirrus Aircraft will continue to focus on product improvement, model upgrades and ongoing generational changes to equip its aircraft with new technologies and designs to consolidate the leading position of the industry. Meanwhile, the Company intend to adopt a series of measures, including monetize installed base through establishing, among many things but not limited to, new maintenance programs, and expanding aircraft management solutions and an array of useful customer services, enhance flight training solutions, advance and expand its aircraft and services portfolio, advance production capabilities, expand its markets globally and establish on-demand personal aviation solutions, to support the future business development and the long-term steady growth of the Company.In recent, as part of the ongoing efforts to increase the capacity and efficiency of the manufacturing facilities, the Company has also completed significant improvements in its manufacturing facility in Grand Forks, including expanded autoclave and mold capacity. In addition, the Company continues to increase the areas of the production facilities in which the Company has implemented its Cirrus Operating System (COS) which continues to increase the operating efficiency. Cirrus Aircraft anticipates these continued improvements will help increase and support future production.In regards to the marketing strategy, the Company adjusted its sales structure in the United Kingdom and France from CSAs to direct sales, which the Company anticipates will drive growth in these markets by developing direct relationships with the customers earlier in the sales cycle, maintaining closer relationships throughout the customers’ ownership experience and allowing the Company to strategically and directly drive sales and marketing initiatives. Moreover, the Company continues to expand the investment within its product portfolio. In April 2024, the Company received the production certificate from Federal Aviation Administration of the U.S. Department of Transportation for its SR10 aircraft, which is the first of its kind clean sheet design exclusive to training the next generation of pilots. - End -About Cirrus Aircraft LimitedCirrus Aircraft Limited is a pioneer and an established global market leader in the personal aviation industry, according to Frost & Sullivan. The Company designs, develops, manufactures, and sells premium aircraft recognized across the personal aviation industry, which incorporate innovations in safety, technology, connectivity, performance, and comfort. The market share of Cirrus Aircraft in the global personal aviation market was 32.0% in 2023 based on the number of units delivered, according to Frost & Sullivan. The Company’s two aircraft product lines, namely SR2X Series and Vision Jet, have successfully set the industry standard for owner-piloted aircraft and are currently certified and validated in more than 60 countries. According to GAMA, SR2X Series has been the best-selling single-engine piston aircraft for 22 consecutive years, while according to GAMA and Frost & Sullivan, Vision Jet has been the best-selling business jet for the last six consecutive years since it first delivered in 2016.This press release is issued by Porda Havas International Finance Communications Group for and on behalf of Cirrus Aircraft Limited. For further information, please contact:Porda Havas International Finance Communications GroupTelephone: 852 3150 6788Email: cirrusaircraft.hk@h-advisors.global Copyright 2024 ACN Newswire via SeaPRwire.com.
More
CIMC Group Announces 2024 Interim Results ACN Newswire

CIMC Group Announces 2024 Interim Results

Financial HighlightsRMB millionFor the 6 months ended 30 June 20242023Change24Q224Q1ChangeRevenue79,11560,57430.61%46,67232,44343.86%Operating profit2,1151,64528.60%1,708407319.8%Net profit1,39599040.85%1,177218440.12%Net profit attributable tothe Company and other equity holders of the Company866399117.23%78284835.19%Net profit attributable to shareholders and other equity holders of the Company after deducting non-recurring profit and loss820977(16.00%)595225164.48%Results Highlights1.The container manufacturing business segment maintained a global leading position with significant improvement in results: Benefiting from the increase in the container trade transportation demand and uncertain events such as the Red Sea incident, which led to lower the efficiency of container transportation, the sales volume of dry containers recorded a 425.54% growth year-on-year. In the first half of the year, the revenue of the container manufacturing business was RMB24.95 billion, representing a year-on-year increase of 83%, and net profit increased by 66% to RMB1.276 billion.2.Significant growth in offshore engineering revenue: Benefiting from the continued recovery of the offshore engineering equipment market, the revenue of this business segment grew significantly by 89% year-on-year to RMB7.78 billion. New orders increased by 20.1% year-over-year to US$1.79 billion, and the accumulated value of orders on hand increased by 20.9% to US$6.18 billion, of which the proportion of oil and gas business, wind power installation vessels, and ro-ro ships was approximately 2:1:1. The net loss continued to narrow by 54% to RMB84 million.3.Steady operation in two business segments for road transportation, energy, chemical, and liquid food: The vehicle business achieved revenue of RMB10.7 billion and net profit of RMB574 million, with its market share maintaining the number one position domestically; Revenue from CIMC Enric grew 6.7% year-over-year to RMB11.48 billion, and the orders on hand reached a record high of RMB29.35 billion.HONG KONG, Aug 29, 2024 - (ACN Newswire via SeaPRwire.com) - China International Marine Containers (Group) Co., Ltd. (“CIMC Group” or the “Group”, stock code: 000039.SZ/02039.HK) is pleased to announce the unaudited interim results for the six months ended 30 June, 2024 (the “Reporting Period”). The management of CIMC Group said, “In the first half of 2024, global commodity trade demand rebounded, the container market stabilised and recovered, global energy security and consumer demands increased, and the global shipping and offshore engineering market environment continued to improve. Based on the continuously consolidating foundation of its global operation platforms, we successfully navigated regional risks and achieved stable and high-quality development.In the first half of the year, the Group achieved revenue of 79.1 billion, increased by 30.61% year-over-year, with a gross profit margin maintained at 10.73%. The net profit attributable to the parent company was approximately RMB870 million, which grew substantially 117% year-over-year. During the period, the Group's container industry maintained its global industry-leading position, and its road transportation, vehicles, energy/chemical/liquid food equipment, and offshore engineering businesses also enhanced strong global competitiveness. The Group’s domestic revenue accounted for approximately 45.55% and its overseas revenue accounted for approximately 54.45%, which was flat as compared with the same period last year, maintaining a sound market landscape.”Segments Results (RMB million)1H2024 Business indicatorsRevenueAs % to the total revenueGross profitAs % to the gross profitGross profit marginNet profitContainers manufacturing24,95031.54%3,04335.85%12.20%1,276Road transportation vehicles10,70013.52%1,59518.80%14.91%574Energy, chemical, and liquid food equipment12,12115.32%1,60118.86%13.21%242Offshore engineering7,7849.84%3894.58%4.99%(84)Airport facilities and logistics equipment, fire safety and rescue equipment2,4033.04%4945.82%20.54%37Logistics services14,08917.81%87710.34%6.23%204Recycled load1,1971.51%1441.21%12.05%(49)Main segments above73,24392.58%8,14295.94%11.12%2,200A review of the main businesses is as follows:In the logistics field:In the container manufacturing business, the demand for global goods trade picked up, and uncertain events such as the Red Sea incident led to the detour of European routes, which lowered the efficiency of container transportation, and the demand for containers increased. The production and sales volume of the Group’s container manufacturing business witnessed a significant year-on-year increase. In particular, the accumulated sales volume of dry containers reached 1,382,700 TEUs (same period in 2023: 263,100 TEUs), representing a year-on-year increase of approximately 425.54%. The accumulated sales volume of reefer containers reached 44,700 TEUs (same period in 2023: 51,500 TEUs), representing a year-on-year decrease of approximately 13.2%. During the period, the container manufacturing business of the Group recorded a revenue of RMB24.95 billion (same period in 2023: RMB13.668 billion), representing a year-on-year increase of 82.54%, and a net profit of RMB1.276 billion (same period in 2023: RMB0.768 billion), representing a year-on-year increase of 66.25%. During the period, the Group took decisive action in response to the surging transportation demand in the container transportation market and the issue of lower container turnaround efficiency due to the detours caused by the Red Sea incident, resulting in significant improvements in production efficiency and delivery capabilities, further boosting overall operational efficiency and market competitiveness.Driven by similar factors, in the logistics services business, both business volume and profitability of most products of the Group recorded considerable year-on-year growth in the first half of the year, with more notable growth in the second quarter as compared to the first quarter. During the period, the logistics services business of the Group realised a revenue of RMB14.089 billion (same period in 2023: RMB9.132 billion), representing a year-on-year increase of 54.28%, and a net profit of RMB204 million (same period in 2023: RMB55 million), representing a year-on-year increase of 274.74%. In the first half of the year, the sea transportation business performed well due to the multiple measures and proactive responses, ranking CIMC Wetrans as TOP 13 on Transprot Topic’s Global Sea Transportation Enterprise List for 2024, the third place among Chinese enterprises.In the road transportation vehicles business, CIMC Vehicles actively forges new quality productivity, and continues to deepen the “StarLink Project”. During the first half of the year, against the backdrop of the industry bottoming out, it rises to the challenge and breaks through against the trend, its market share has increased, maintaining the number one position domestically. In the specialty vehicles business, CIMC Vehicles continued to consolidate its domestic market and expand into overseas markets, and actively developed integrated new energy products, leading to the small-scale delivery of the industry-first integrated hybrid electric semi-trailer tractor mixer. During the period, CIMC Vehicles achieved revenue of RMB10.7 billion (same period in 2023: RMB13.47 billion), representing a year-on-year decrease of 20.56%; achieved a net profit of RMB574 million.In the airport facilities and logistics equipment, fire safety and rescue equipment business, CIMC TianDa through integrating production and marketing layouts both at home and abroad, actively promoted integrated operations, thereby reducing overall operating costs and striving to maintain its advantages and keep its long-term stable growth of profitability in a fiercely competitive environment. During the period, the revenue of the business segment grew by 5.31% to RMB2.403 billion, and net profit increased by 364.81% to RMB37 million. In the first half of 2024, the increase in the acceptance and delivery of passenger boarding bridges and fire trucks had driven the increase in the revenue from the airport facilities and logistics equipment, and fire safety and rescue equipment businesses as compared with the same period last year, and total profit of the segment also increased year-on-year. In terms of newly signed orders, the demand in the airport facilities market continued to recover, and the program to issue RMB1 trillion treasure bonds in China boosted the rise in demand for fire safety equipment, owing to which total newly signed orders maintained overall growth.In the energy industries field:In the offshore engineering business, in the first half of the year, the international oil prices were at a high level, which stimulated an increase in demand for the oil and gas production platforms, the continuous growth in marine operation activities drove the utilisation ratio of and the rental for offshore engineering equipment to be on the rise, and the offshore engineering equipment market continued to recover. During the period, as new orders for offshore engineering entered the construction period successively, the offshore engineering business of the Group recorded a revenue of RMB7.784 billion (same period in 2023: RMB4.119 billion), representing a year-on-year increase of 88.95% growth. In terms of new orders: the value of effective orders/orders won increased by 20.1% year-on-year to US$1.79 billion (same period in 2023: US$1.49 billion) as of the end of June, including two FPSO and three ro-ro ships. The accumulated value of orders on hand increased by 20.9% to US$6.18 billion (same period in 2023: US$5.11 billion), of which the proportion of oil and gas business, wind power installation vessels, and ro-ro ships was approximately 2:1:1, which had effectively eased the periodic fluctuation of the oil and gas market, demonstrating that successful strategic transformation had been achieved.In the offshore engineering asset operation business, the Group’s on-lease platforms maintained its high-quality services and occupation rates and continued to provide customers with high-quality and efficient services. Against the backdrop of global energy security and growing consumer demand, the offshore engineering market remained active. The deep-water platform market has benefited from continued investment in development by international oil companies. According to Rystad’s forecast, global capital spending on deepwater oil and gas drilling will increase 10% year-on-year, hitting the highest level in over 10 years. The increase in global demand and the reduction in drilling platform availability are jointly driving the continued growth in day rates and utilisation rates. During the period, Caspian Driller, one of the Group’s jack-up drilling platforms, was granted a 3+2 year contract extension by the customer; and Deepsea Yantai, one of the Group’s mid-deepwater semi-submersible drilling platforms, was granted a contract extension by the customer, and the new leases increased by over 10% in daily rate as compared to the current contracts.In the energy, chemical, and liquid food equipment business, this segment achieved a revenue of RMB12.121 billion (the same period last year: RMB11.388 billion), representing a 6.43% year-over-year growth, and net profits of RMB242 million (the same period last year: RMB435 million), representing a year-on-year decrease of 44.52%. In which, CIMC Enric registered a revenue of RMB11.48 billion (same period last year: RMB10.76 billion), representing a year-on-year increase of 6.7%, newly signed orders amounted to RMB16.4 billion (the same period last year: RMB12.67 billion), representing a year-on-year increase of 29.5%, orders on hand as of the end of June amounted to RMB29.35 billion (the same period last year: RMB20.6 billion), representing a significant year-on-year increase of 42.5%, reaching a record high. The clean energy segment saw steady revenue growth, with strong demand for LNG storage and transportation equipment, as well as LNG on-vehicle cylinders. The small and medium-sized liquefied gas carriers market remained highly prosperous. In the hydrogen energy field, we successfully acquired the core assets of Beijing Zhonglian Sheng during the period and won the bid for China's largest ammonia, hydrogen, and alcohol tank project. In the chemical and environment segment, its tank container global market share remained number one and demonstrated resilient development. In the liquid food segment, it actively responded to market changes and seized growth opportunities in the domestic liquor market, winning bids for multiple liquor projects.Outlook and future developmentLogistics SegmentIn the container manufacturing business, according to CLARKSONS’ forecast in July, the growth of global container trade will significantly increase from 0.7% in 2023 to 5.1% in 2024, and in 2025, the global container trade is expected to see further growth of 2.9%, which suggests an optimistic and stable outlook for the transportation demand in the container transportation market. To cope with the risk of container shortage brought about by these uncertain events, customers’ willingness to spare containers will increase, coupled with the stable replacement rate of old containers, the demand for new containers is expected to be underpinned by the stable fundamentals during 2024–2025.In the road transportation vehicle business, in the second half of 2024, the demand for logistics and transportation in China will gradually recover, and the semi-trailer industry in China will accelerate its transformation and upgrading towards a new development stage of regularisation, standardisation, intelligence, and electrification. As the U.S. policy trend of interest rate cuts becomes increasingly certain, the demand for semi-trailers in North America may be released; and as the regulation on sustainable development of the European semi-trailer industry becomes stricter and the demand for multimodal transportation grows, the European semi-trailer industry, which is experiencing a slowdown in demand, may be benefited. There is an expected recovery in the specialty vehicle industry, with the penetration rate of new energy specialty vehicles gradually increasing and the regularisation process of specialty vehicle transportation speeding up.Energy SegmentIn the energy, chemicals, and liquid food equipment business, the latest report of Goldman Sachs Group predicts that by 2029, global investment in LNG is expected to increase by more than 50%, and global LNG supply will surge by 80% by 2030. In the domestic market, IEA predicts that by 2030, China’s share in effective LNG contracts will be doubled, increasing from 12% in 2021 to about 25%. As a leading enterprise in advanced intelligent manufacturing of clean energy equipment, driven by the increase in LNG demand, CIMC Enric is expected to continue to benefit from the related storage and transportation equipment and engineering business and will continue to expand business opportunities in overseas markets such as Southeast Asia, Africa, and the Middle East. CIMC Enric will pay attention to the changes and opportunities in the hydrogen energy market, continue to deepen the whole industrial chain layout and integrate solution capability of “preparation, storage, transportation, filling and application. In addition, leveraging its extensive years of experience in production technology and quality management in the tank container manufacturing field and the market share of its medical equipment components business, the Group will be actively monitoring changes in the global liquid food market, and maintaining close attention on emerging opportunities in the domestic liquor and other new industry segments.In the offshore engineering business, due to the relatively high oil prices continuing to stimulate oil and gas production platforms, the offshore engineering construction market was entering an upward cycle. The FPSO/FLNG market has high short-term demand and ample long-term project reserves. It is anticipated that offshore engineering manufacturers will maintain a high capacity utilisation rate over the next 3–5 years. Leveraging the advantage of the industrial cluster effect, the offshore engineering manufacturers in China are competing for orders with high technical thresholds with those in Japan and South Korea. In the second half of 2024, the Group’s offshore engineering business will continue to actively promote transformation, and integrate the industry mapping. Taking offshore oil and gas as the foundation, the Group will gradually expand to new energy sources to form a business portfolio that dilutes the impacts of the industrial cycle.Financial and Asset Management SegmentThe offshore engineering asset operation and management business of CIMC will continue to capitalise on the active cycle in the offshore engineering market and fully utilise the advantages in the entire industrial chain to advance market development, thereby improving asset rental rates. By focusing on customer needs, the Group will enhance customer satisfaction and explore future cooperation opportunities. Through lean management, the Group will continuously strengthen cost control and core competitiveness, promoting steady growth in profitability.The Group's management concludes, “In the first half of the year, the Group has consolidated and enhanced its leading industry position in its existing core businesses, while also focusing on expanding multiple strategic emerging businesses. Our core businesses have achieved steady and high-quality growth, and our effective global business layout has also effectively mitigated the impact of recent global market cyclical fluctuations.Looking ahead to the second half of the year, CIMC will follow the guidance of national policies based on the situation in the new development stage, and will also continue the implementation of the strategic theme of “accelerating the construction of new growth drivers and focusing on promoting high-quality development. We will firmly grasp the important opportunities of new quality productivity, the "Belt and Road" initiative, the unified large market, scientific and technological innovation, and green development. By consolidating and enhancing our leading industry position in our existing core businesses, we will continue to activate new business value and new driving forces, to achieve our goal of high-quality growth."-Ends-About China International Marine Containers (Group) Co., Ltd.The CIMC Group is a world leading equipment and solution provider in logistics and energy industries, and its industry cluster mainly covers logistics and energy fields, strengthening its position as a global market leader. In the logistics field, the Group still adheres to taking container manufacturing business as its core business, based on which to develop road transportation vehicles business, airport facilities and logistics equipment/fire safety and rescue equipment business and to a lesser extent, logistics services business and recycled load business providing products and services in professional field of logistics; in the energy field, the Group is principally engaged in energy/chemical/liquid food equipment business and offshore engineering business; meanwhile, the Group also continuously develops emerging industries and has finance and asset management business that serves the Group itself. As a diversified multinational industrial group that shoulders the mission of global serving, CIMC owns 3 listed companies and over 300 member enterprises in Asia, North America, Europe, Australia and others, and extensive customers and sales networks covering more than 100 countries and regions. During the year, the Group recorded a revenue of RMB127.81 billion, with gross profit margin remained at 13.77% and net profit of RMB 1.863 billion. The Group was ranked 170th in the Fortune 500 China 2023. For more information, please visit http://www.cimc.com/. Copyright 2024 ACN Newswire via SeaPRwire.com.
More
Pioneering Green Growth with Technological Innovation and Accelerating Global Strategy ACN Newswire

Pioneering Green Growth with Technological Innovation and Accelerating Global Strategy

HONG KONG, Aug 29, 2024 - (ACN Newswire via SeaPRwire.com) - Tianneng Power International Company Limited (the “Company”, together with its subsidiaries, collectively the “Group” or “Tianneng”) (stock code: 00819.HK), a leading company in China's new energy battery industry, announced its interim results for the six months ended 30 June 2024 (the “Reporting Period”).In the first half of 2024, Tianneng focused on building new quality productivity by utilizing the three driving forces of "industry, technology and capital" and the three interlinked transformations of "digitalization, platform-based operation and internationalization" to form a new development pattern. The Group adhered to the concept that "technological innovation is the core element of developing new quality productivity", further upgraded and optimized the production processes of lead-acid batteries, and actively expanded the layout and applications of emerging batteries such as lithium, hydrogen, sodium, and solid-state batteries. In addition, it strived to address global climate change challenges by enhancing efficiency and environmental protection through green and intelligent manufacturing, developing a circular economy, and building a sustainable supply chain that aligns with a series of development goals such as high-quality development and modern governance of China.During the reporting period, the Group achieved revenue of approximately RMB 49.915 billion, representing an increase of approximately 20.36% compared to the same period last year. Profit attributable to owners of the Company was approximately RMB 928 million, representing a growth of approximately 1.09% compared to the same period last year. While actively exploring the development of emerging businesses, Tianneng invested significant effort in consolidating and strengthening its leading position in its core business. The cornerstone business of lead-acid batteries generated revenue of approximately RMB19.252 billion. In the field of new energy batteries, Tianneng accelerated the development of lithium-ion battery for ESS, facilitated the iteration of hydrogen fuel cells and sodium-ion batteries, and achieved breakthroughs in key technologies and applications in diverse scenarios. In the field of circular economy, Tianneng established a battery recycling green industry chain integrating production, recycling, smelting, and reproduction, with the circular industry generating revenue from external customers of approximately RMB1.554 billion.Breaking Barriers through Continuous Technological InnovationThe Group has established a dual-core strategy in "motive batteries and energy storage systems", achieved a parallel development in the traditional track with both lead and lithium technologies, and accelerated the development of hydrogen fuel cells, sodium-ion batteries, and solid-state batteries in emerging tracks. In terms of motive batteries, Tianneng has successively launched the first dedicated lead-acid motive battery for electric motorcycles, the new generation sodium-ion motive battery "Tianna T2" and colloidal batteries for forklifts, catering to a more diverse range of applications. For energy storage, successful developments included the OPzV-1000 valve-regulated colloidal lead-carbon battery, the "Sodium Storage No.1" suitable for energy storage scenarios, and a new generation 5MWh lithium-ion intelligent liquid-cooled energy storage system. These advancements help systems unleash greater value and provide stable and reliable power support for various application scenarios.Upholding Sustainable Development Strategy for Green IndustryAs one of the world's largest lead-acid battery manufacturers, Tianneng utilizes over 90% of its battery products in electric light vehicles, possessing an inherent low-carbon advantage in the transportation industry. Tianneng incorporates green and intelligent manufacturing into its corporate development strategy by optimizing production processes, enhancing automation coverage, and improving production efficiency. By developing and integrating multiple digital management systems, Tianneng elevates the digitalization level of production management, thereby continuously driving the Company towards a more efficient and environmentally friendly future.While focusing on the battery industry, Tianneng is also committed to achieving more efficient resource recovery and recycling. It has established four lead-acid battery circular economy industrial parks and two lithium-ion battery circular economy industrial parks in China. The recovery rates of various materials from waste lead-acid batteries exceed 99%, while the recovery rate of sulfate from waste lithium-ion batteries exceeds 98.5%, and the lithium carbonate recovery rate reaches 90%. For lead-acid battery recycling, Tianneng continuously enhances the capabilities of recovery and disposal and establishes a stable and sustainable supply chain to improve production capacity utilization. The Company now has the capacity to dispose of 1 million tons of waste lead-acid batteries annually. For lithium battery recycling, Tianneng has the capacity to dispose of 10,000 tons of waste ternary lithium-ion batteries annually, with an additional 60,000 tons of new capacity to be put into operation this year. Tianneng consistently innovates battery recycling technologies, and possesses various lithium-ion battery recycling technologies, including intelligent crushing and sorting without discharge, targeted thermal decomposition of dismantled materials, simultaneous disposal of ternary lithium iron phosphate, and lithium extraction through freezing.During the Reporting Period, the Group undertook a waste lead-acid battery recycling and treatment project at the Circular Economy Industrial Park in Changxing County, Huzhou, Zhejiang Province, becoming the first "National Circular Economy Standardization Demonstration Project" in Zhejiang Province. By transforming typical models into national standards, this project has led the development direction of the industry. The Ministry of Industry and Information Technology announced the list of Green Manufacturing for 2023, with Tianneng New Materials Co., Ltd., a subsidiary of the Group specializing in lithium battery recycling, being selected as a national-level "Green Factory".Keeping Up with the Times to Strengthen Brand PromotionIn terms of the marketing, the Group has established an extensive distribution and after-sales service network and has over 3,000 distribution and after-sales service points in China, covering more than 400,000 terminal stores. This network provides replacement and repair services to 400 million users of electric light vehicles, making it one of the most well-known battery brands in the market.Tianneng actively embraces big data technology and the emerging internet market, utilizing digital means to empower marketing efforts and support partners in refined operations and management. During the Reporting Period, the Group deepened the advancement of digital marketing models and upgraded the Tianneng innovative cloud commerce model, significantly optimizing the Group's flexible production. This allows for faster and more accurate responses to changes in market demand, adjustments to production plans, and a notable increase in operational efficiency. It has also established dozens of online and offline integrated service experience centers, which promoted the growth of customized product sales, significantly enhanced the quality and effectiveness of the distribution channels and further strengthened its competitiveness.Marching Forward with Determination to Expand International OperationsWhile consolidating its industry-leading position in China, Tianneng, based on local conditions, has rapidly pushed its battery products and energy solutions into the global market. Tianneng's overseas business layout covers various countries and regions such as Southeast Asia, Europe, and Africa. Dr. Zhang Tianren, Chairman of the Board, was invited to participate in the "China-Vietnam Trade and Investment Cooperation Promotion Forum" in April 2024, and the first overseas intelligent manufacturing base was established in Vietnam, serving as a bridgehead for expanding the Southeast Asian market. The Company successfully contracted with dozens of Tianneng brand overseas partners for overseas terminal distribution and after-sales service network development. It also made frequent appearances at international exhibitions such as the EV TREND KOREA in Seoul and the EES Europe in Munich, Germany, receiving recognition from customers worldwide.Leveraging the technological innovation achievements in green energy products and the industry experience accumulated over the years, Tianneng has set the international market as the new stage for its future development. Following the establishment of local offices, the development of overseas sales channels, and the Vietnam factory construction project, Tianneng will continue to explore overseas markets, actively respond to China's "Belt and Road" initiative, use the Southeast Asian market as an entry point, and collaborate with more like-minded partners to enhance its influence in overseas markets and seize the initiative in international competition.Future OutlookTianneng will adhere to the development direction of "focusing on high-quality development and enhancing sustainability" to accelerate the creation of new quality productivity with Tianneng’s characteristics. With technological innovation as the driving force and structural adjustment as the main theme, the Company will promote the transformation and upgrading of the new energy industry with a focus on nurturing the two major industrial ecosystems of motive batteries and energy storage systems. Meanwhile, based on the entire lifecycle of the battery industry, the Company will utilize the scale advantages of the circular economy to enhance efficiency. Based on its own technological advantages and fully leveraging the supporting and leading role of technological innovation, Tianneng will contribute more clean energy system solutions to the "carbon peaking and carbon neutrality" strategy and make greater contributions to the ecological civilization construction of China. - End -Issued by Porda Havas International Finance Communications Group for and on behalf of Tianneng Power International Limited. For further information, please contact:Kelly FungTel: +852 3150 6788Email: tianneng.hk@pordahavas.com Copyright 2024 ACN Newswire via SeaPRwire.com.
More
DYNASTY’S PROFIT ATTRIBUTABLE TO OWNERS OF THE COMPANY INCREASES BY 73% TO HK$18.5 MILLION IN 1H2024 ACN Newswire

DYNASTY’S PROFIT ATTRIBUTABLE TO OWNERS OF THE COMPANY INCREASES BY 73% TO HK$18.5 MILLION IN 1H2024

Financial Highlights (Unaudited)(HKD Thousand)Six months ended 30 June20242023ChangeRevenue135,347128,168+6%Gross Profit48,76747,212+3%Profit Attributable to Owners of the Company18,51010,712+73%Gross Profit Margin36%37%-1 percentage pointBasic Earnings per Share (HK cents)1.300.90+44%HONG KONG, Aug 29, 2024 - (ACN Newswire via SeaPRwire.com) - Dynasty Fine Wines Group Limited (“Dynasty” or the “Group”) (Stock Code: 00828), a premier grape winemaker in China, today announced its unaudited interim results for the six months ended 30 June 2024.In the first half of 2024, benefiting from new consumption scenarios such as banquets and gatherings nationwide, as well as continuous innovation achieved by the Group in product and consumption scenarios, sales volume of the Group’s products (particularly mid-range grape wine products) increased steadily, with revenue improving by 6% year-on-year to approximately HK$135 million. Government grants received by the Group during the period increased by approximately HK$6.50 million. Profit attributable to owners of the Company also increased significantly by 73% year-on-year to HK$18.5 million in the first half of 2024. Basic earnings per share were approximately HK1.3 cents per share. During the period, due to increase in overall material costs, the Group's overall gross profit margin mildly decreased from 37% for the same period last year to 36%.Sales of white wines products of the Group grew well over the period and served as the Group’s primary revenue contributor. Sales revenue of red and white wines products accounted for approximately 45% and 51% of the Group’s overall revenue respectively for the period. During the period, the gross profit margin of red wine products and white wine products were 33% and 41% respectively (in the first half of 2023: 31% and 45% respectively).The Group has continued to strengthen its presence in Ningxia and Xinjiang. This morning, Ningxia Tianxia Winery (Phase I) was completed three months ahead of schedule and officially commenced production. The grand completion cum grape pressing ceremony was held at the Ningxia Tianxia Winery, situated nearby Eastern foothill of Helan mountain, Ningxia, which is one of the key quality grape producing areas in China. The winery will integrate pressing, fermentation, processing, testing and research and development as a whole, with an annual production and processing capacity of 5,000 tonnes. The completion and commissioning of the project will greatly increase Dynasty’s capacity to produce premium wines, become a new driver for the Group’s long-term stable development and create new quality productive forces for the Group’s development. It is therefore an important milestone in Dynasty’s development history.The completion cum grape pressing ceremony of Ningxia Tianxia Winery (Phase I)The Group has been actively pursuing innovation, embracing the “5+4+N” product strategy, with “N” standing for developing various customised products and continuously creating new products. During the period, the Group launched a new high-end product, i.e. Dynasty Chinese Zodiac Commemorative Dry Red Wine for the Jia Chen Year of Dragon, integrating the high quality with the Chinese zodiac culture and the leading rise of Chinese-style fashionable products. In addition, the Group launched a new product, Inherit Series “Passing on the Glory, Continuing the Brilliant Heritage”, at the 110th China Food & Drinks Fair in March this year, as well as other new products launched in the period such as Long Yun Series, Cabernet Reserve etc., to further improve its product matrix and provide consumers with diverse consumption choices. With leading and well-proven technologies it prides, the Group carried out comprehensive upgrade of its production techniques, packaging design, etc. With China chic on the rise, the new upgraded design is set to resonate with Chinese consumers confident of their culture, help strengthen awareness of the Dynasty brand and attract mainstream consumers fancying China-made products and China chic.In addition to enriching the product matrix, the Group is accelerating the innovation of consumption scenarios and enhancing and strengthening the wine cultural experience. In June this year, Dynasty Starry Wine Bar was officially opened in Meijiang, Tianjin, the base of Dynasty. Starry Wine Bar is a pop-up offline bar meticulously designed by Dynasty to innovate the product experience, meet the diversified needs of consumers, and create new consumption scenarios in the country. It is committed to making consumers feel the warmth of the brand and recognise the value of the brand, thereby attracting more consumers through innovation.During the period, the Group continued to develop the “Dynasty Tavern” through online channels, creating a series of product promotion articles on the WeChat official account of Dynasty Wines, and promoting Dynasty’s major mainstream products using new media formats. In addition, it integrated the night market environment to expand various wine drinking scenarios and promote Dynasty’s younger products.Moreover, the Group sold chateau wine imported from France and other foreign branded wines in Chinese market through the Group’s existing distribution network to introduce some classic “old world” and “new world” varietals to cater for part of the market that prefers the taste of foreign premium wines.Regarding online sales, the e-commerce team of the Group comprehensively operated online stores itself on the traditional e-commerce platforms, such as JD.com, Tmall and Pinduoduo for product sales, as well as comprehensive innovation on its brand, product categories, and business systems, procedures and models via interest-based e-commerce platforms, including RED, Kuai and TikTok. Such efforts facilitated the Group’s autonomous brand communications so that it could continue to gain the attention of mainstream consumer groups and demographic segments, and enhance effective market penetration of the Group’s products targeted at young consumers. The e-commerce team also actively cultivate e-commerce live broadcasting talents to further expand its sales channels so as to build up a new customer base. The Group continues investing resources for improvement of the online sales channels and optimisation of online stores interface so as to adapt to the changing customer consumption behaviour in China, and keeps promoting the exclusive products series for e-commerce platforms through channels such as live streaming or broadcasting.Mr. Wan Shoupeng, Chairman of Dynasty, concluded, “Looking ahead to the second half of 2024, the Group will keep strengthening presence in Ningxia and Xinjiang to secure the supply of quality grapes and grape juice. Ningxia Tianxia Winery (Phase I) has completed construction and begun operation, which will become a new long-term and stable economic growth point of the Group and help the regional presence and layout of Dynasty, as well as in line with the overall planning and industry planning for the development of China’s wine industry. The Board currently remains cautious on the business prospects in the second half of 2024 and the Group will continue to proactively develop the new marketing prospects by innovation in products categories and consumption scenarios, carrying out cross-industry co-operations in order to boost sales volume, and be in line with the country’s commitment to stimulating domestic consumption.” – End –About Dynasty Fine Wines Group LimitedDynasty Fine Wines Group Limited was listed on the Main Board of The Stock Exchange of Hong Kong Limited with the stock code 00828 on 26 January 2005. Founded in 1980, Dynasty is the premier grape winemaker in China. It is principally engaged in the production and sale of grape wine products under its reputable “Dynasty” brand. Dynasty is the first Sino-foreign joint venture wine company in China with Tianjin Food Group Limited and the French grape wine giant, Remy Cointreau, as its current major shareholders. The Group produces and sells more than 100 grape wine product series, and introduces imported wine products, providing high-quality and value-for-money grape wines to the full range of consumer groups in China. Copyright 2024 ACN Newswire via SeaPRwire.com.
More
Banle Group Expands Global Port Coverage to Over 60 Ports ACN Newswire

Banle Group Expands Global Port Coverage to Over 60 Ports

HONG KONG, Aug 29, 2024 - (ACN Newswire via SeaPRwire.com) - CBL International Limited (the “Company” or “CBL”) (NASDAQ: BANL), the listing vehicle of Banle Group (“Banle” or “the Group”), a reputable marine fuel logistic company in the Asia-Pacific region, proudly announces a significant milestone by expanding its global port coverage to over 60 ports across fourteen countries and regions in four continents.This development underscores Banle's commitment to expanding its global presence and entering new markets, demonstrating the company's continued efforts to open new service ports and increase coverage for both existing and new customers. The company now provides bunkering services in Belgium, China, Hong Kong, India, Japan, Korea, Malaysia, Mauritius, Panama, Singapore, Taiwan, Thailand, Turkey, and Vietnam, representing a 70% increase in port coverage since its Nasdaq listing in March 2023, solidifying Banle's position as a major player in the industry.The Group's footprint includes nine out of the top ten container ports globally by throughput volume in 2023, highlighting its dominance in key maritime hubs. The Asia Pacific region, accounting for 70% of global container port throughput, remains a key focus for Banle, while the company continues to expand its presence in Europe and other regions.The company is actively preparing to capitalize on the growing demand for greener marine fuels, driven by international regulations like the FuelEU Maritime initiative and the IMO's strategy for greenhouse gas reduction. Banle has obtained the required ISCC EU and ISCC Plus certifications to comply with these regulations.As a pioneer in providing stable biofuel supply at major ports, Banle has achieved key milestones in biofuel bunkering services, including:— July 14, 2023: Commencement of biofuel supply in Hong Kong.— September 5, 2023: First export to China cargo supply.— March 15, 2024: Introduction of biofuel supply in Guangzhou, China.— April 13, 2024: Launch of biofuel supply in Shenzhen, China (Yantian).— June 28, 2024: Inaugural biofuel supply in Port Klang, Malaysia.According to BIMCO, the container shipping market has exceeded growth expectations, with forecasts predicting a 5 – 6% increase in container volumes for 2024 and a 3 – 4% increase for 2025. Banle is well-positioned to capitalize on this growth, continuing to facilitate essential bunkering services that support the efficient and profitable operations of container liners globally."Since our Nasdaq listing, we have made remarkable strides in expanding our port coverage and enhancing our service offerings to meet the growing demands of our customers, the international shipping companies," said Mr. Teck Lim Chia, Chairman & CEO of Banle Group. "Our expansion into Europe, with establishments in Ireland, underlines our commitment to developing our green marine fuels business, which is critical for our long-term sustainability goals."About the Banle GroupCBL International Limited (Nasdaq: BANL) is the listing vehicle of Banle Group, a reputable marine fuel logistic company based in the Asia Pacific region that was established in 2015. We are committed to providing customers with one stop solution for vessel refuelling. Banle Group’s business activities are primarily focused in over 60 major ports covering Belgium, China, Hong Kong, India, Japan, Korea, Malaysia, Mauritius, Panama, Singapore, Taiwan, Thailand, Turkey and Vietnam as of 28 August 2024. The Group actively promotes the use of alternative fuels and is awarded with the ISCC EU and ISCC Plus certifications.For more information about our company, please visit our website at: https://www.banle-intl.com.Forward-Looking StatementsCertain statements in this announcement are not historical facts but are forward-looking statements. Forward-looking statements generally are accompanied by words such as “believe,” “may,” “could,” “will,” “estimate,” “continue,” “anticipate,” “intend,” “expect,” “plan,” “should,” “would,” “plan,” “future,” “outlook,” “potential,” “project” and similar expressions that predict or indicate future events or trends or that are not statements of historical matters, but the absence of these words does not mean that a statement is not forward-looking. These forward-looking statements include, but are not limited to, statements regarding estimates and forecasts of other performance metrics and projections of market opportunity. They involve known and unknown risks and uncertainties and are based on various assumptions, whether or not identified in this press release and on current expectations of BANL’s management and are not predictions of actual performance. These forward-looking statements are provided for illustrative purposes only and are not intended to serve as and must not be relied on by any investor as, a guarantee, an assurance, a prediction or a definitive statement of fact or probability. Actual events and circumstances are difficult or impossible to predict and will differ from assumptions. Many actual events and circumstances are beyond the control of BANL. Some important factors that could cause actual results to differ materially from those in any forward-looking statements could include changes in domestic and foreign business, markets, financial, political and legal conditions, geopolitical disruptions and other events that result in material changes in fuel prices. The Company undertakes no obligation to update or revise publicly any forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to review other factors that may affect its future results in the Company's registration statement and other filings with the SEC.For more information, please contact:CBL International LimitedEmail: investors@banle-intl.comStrategic Financial Relations LimitedShelly Cheng Tel:(852) 2864 4857Iris Au Yeung Tel:(852) 2114 4913Email: sprg_cbl@sprg.com.hk Copyright 2024 ACN Newswire via SeaPRwire.com.
More
Yunkang Group’s 2024 Interim Revenue Reaches Approximately RMB380 Million ACN Newswire

Yunkang Group’s 2024 Interim Revenue Reaches Approximately RMB380 Million

HONG KONG, Aug 28, 2024 - (ACN Newswire via SeaPRwire.com) - Yunkang Group Limited ("Yunkang" or the "Group"; Stock Code: 2325), a leading medical operation services provider in China, has announced its interim results for the six months ended 30 June 2024 (the "Reporting Period"). In the first half of 2024, the Group continued to deeply implement its overall business philosophy of “in-depth services and lean operations”. On the one hand, the Group constantly deepened the model of diagnostic testing services for medical institution alliances, rapidly replicated the joint innovation platform for diagnostic testing, created a new model for innovative medical centers, and focused on “Artificial Intelligence (“AI”) + medical care” to achieve remarkable results in product innovation + model innovation and promote high-quality development of the industry. On the other hand, it leveraged on the fast-growing digital technologies, while adhering to reduce costs and increase benefits to continuously build lean operation capabilities.During the Reporting Period, due to the challenges brought by the macro environment, the in-depth changes in the medical service market and the fierce market competition, the Group’s short-term results did not meet expectations, recording a total revenue of RMB379.9 million, of which, revenue from diagnostic testing services for medical institution alliances, diagnostic outsourcing services and diagnostic testing services for non-medical institutions amounted to RMB182.3 million, RMB179.6 million and RMB18.1 million, respectively. If excluding the impact of revenue from phased testing and screening services nationwide at the beginning of 2023, the diagnostic testing services segment provided by the Group for medical institution alliances continued to maintain high-quality growth, contributing approximately 48.0% of the revenue, making it the largest source of revenue for the Group. The Group’s gross profit was RMB128.2 million and loss attributable to owners of the Company was RMB126.1 million.The innovative model of diagnostic testing for medical institution alliances has achieved remarkable results, empowering the development of hospitals through in-depth servicesDriven by the continuous increase in favorable national policies, the market demand for medical institution alliances has been gradually released. Leveraging the overall advantages of the Group’s professional, standardized and digitally intelligent solutions for the construction of regional medical institution alliances, the Group’s innovative business model – the provision of diagnostic testing services to medical institution alliances has maintained high-quality and healthy development for many years. As at the end of the Reporting Period, the Group had successfully provided professional diagnostic services for more than 1,500 medical institutions in collaboration with medical institution alliances under over 430 jointly constructed on-site diagnostic centers for medical institution alliances across the country and had created a number of benchmark joint projects, so as to facilitate the rapid development of medical institution alliances. Apart from developing customers of the joint construction business with medical institution alliances, the Group also attached importance to the deep cultivation of existing clients and lean operations. The Group not only provided “3+1” (i.e. tumor, infection, genetics and reproduction + precision medicine) technical system support but also provided support to the in-depth service system to empower the demand and long-term development of hospitals with in-depth services.Disease- and clinical-oriented to persistently enhance product competitivenessThe Group has always adhered to the “disease and clinical” oriented service concept and built a series of high and new technology platforms including PCR, protein high-throughput sequencing, gene chip, molecular diagnosis, cytogenetic, digital remote pathology and ultramicro pathology. The technology platforms can provide over 3,500 testing items, and the annual testing specimen volume exceeds 10 million. It also has developed diversified and targeted solutions and services for clinical application scenarios in different regions and different kinds of medical institutions. In recent years, the Group has continuously increased its investment in product research and development. In the first half of 2024, the Group has launched more than 500 new testing projects, which are far ahead of its peers. New projects launched during the Reporting Period with clinical needs as the core include 12 key featured products represented by dried blood spot vitamin D, allergy gene V2.0, urinary and fungal tNGS, as well as new projects such as targeted sequencing of 158 respiratory pathogens, targeted sequencing of 265 common pathogens, intestinal flora detection (16srDNA sequencing), congenital adrenal hyperplasia (CAH) gene detection (third generation sequencing), and deafness gene screening (321 sites), which have been widely recognized by the market.The joint innovation platform for diagnostic testing was replicated rapidly, with product innovation + model innovation entering the harvest stageIn recent years, the Group pioneered the creation of “joint innovation platform for diagnostic testing”, which has successfully developed detection products for different infection syndromes in various fields such as respiratory tract infections and central nervous system infections. During the Reporting Period, the Group continued to deepen its cooperation with many top hospitals such as Guangdong Provincial People’s Hospital with which the Group has contracted and continued to develop new products and technologies and promote them to the market, which was widely acclaimed by clinicians. At the same time, the Group attached great importance to the continued development of the joint innovation platform for diagnostic testing, it has so far cooperated with dozens of top domestic medical institutions in this innovative model. By giving full play to the top hospitals’ technological leadership, as well as leveraging on the Group’s platform foundation and innovative integration advantages in cutting-edge biotechnology, AI, cloud computing, big data and other advanced digital technologies, it will jointly explore scientific research and achievement transformation in various clinical specialty areas. During the Reporting Period, the innovative products developed based on the joint innovation platform for diagnostic testing have exceeded the annual level of the previous year in terms of testing volume and testing revenue, which has injected new momentum into the Group’s long-term high-quality growth.Create a new model of innovative medical center, promote the development of medical technology industryIn terms of innovation in the medical technology industry, the Group joins hands with various partners and lays emphasis on policy guidance, clinical development, technological breakthroughs, industrial services and application promotion in a bid to explore a new cooperation model for joint innovation and cooperation with medical schools, local governments and medical institutions. Subsequent to the Reporting Period, the Group has signed strategic cooperation agreements with the People’s Government of Ouhai, Wenzhou City and Wenzhou Medical University. In the future, all parties will focus on the core areas of the biopharmaceutical industry to orderly promote the establishment of several key projects such as joint innovation and transformation platforms, public service platforms, and medical big data research platforms, regional diagnosis sharing centers and innovative talents training base to promote the rapid transformation and industrial application of scientific research results. The Group will fully support Wenzhou Medical University and its affiliated hospitals, promote the transformation of scientific research results into practical applications, and strengthen the development of clinical disciplines and superior specialties, so as to truly improve the regional medical level.Focus on “AI + medical care” to empower high-quality development of the industryThe Group has continuously improved its medical testing technology research and development and digital application, further explored cutting-edge medical fields such as remote pathology, digital pathology and AI, and built a professional service platform “AI + medical care”. Combining with its top ten digital “cloud” operation systems, the Group helps partner hospitals to accomplish remote guidance, consultation, training and other services, and accelerate the interconnection of information within the medical institution alliances. As at the end of the Reporting Period, the remote pathology consultation platform, a digital IT platform independently developed by the Group which owns all intellectual property rights thereon, covers more than 600 medical testing items and has provided standardized and intelligent professional pathology technical services to nearly 300 medical institutions. It is one of the leading remote pathology platforms in China with the most access to hospitals, and it assists medical institutions nationwide to improve examination quality and diagnosis efficiency.In terms of the application of AI-assisted diagnosis, the Group adheres to the strategy of “introducing one project once it is mature” and has successfully introduced projects such as pathological DNA polyploid AI-assisted diagnosis, cervical liquid-based cell AI-assisted diagnosis, and chromosome AI analysis, leading to the great enhancement of diagnostic efficiency. In addition, through the perfect combination of pathological AI-assisted diagnosis and remote pathology diagnosis platform, the Group has also realized the upgrade of the human-machine remote mode of “preliminary screening by AI and review by pathologist”, significantly improving the efficiency of film reading.Lean operations to reduce costs, increase benefits and improve the operation efficiencyDuring the Reporting Period, the Group launched Phase II of the Robust Project, aiming to continue to deepen the results of Phase I of the Project, to consolidate the foundation of the Group’s lean operations and management, and further improve the efficiency of the Group’s use of resources to reduce costs and increase benefits through minimizing operating costs and optimizing operation platform. Through the perseverance and efforts of the entire Group, Phase II of the Robust Project has achieved various outcomes such as improving the establishment of various operating rules and systems, optimizing the core operation and management processes, further standardizing the process supervision mechanism, and improving supervision efficiency; supported by the Group’s “cloud” system, a structured operation data support system established through IT-based means. Through lean management, the Group will comprehensively reduce costs and increase benefits from all aspects of corporate operations such as marketing, laboratories, supply chain, logistics and human resources, the outcomes of which will be seen in the second half of the year.In the future, under the Group’s business philosophy of “in-depth services and lean operations”, the Group will continue to adhere to the principles of innovation and service orientation and actively promote the development of new quality productivity in the medical and health field by leveraging on its strong technology research and development capabilities and profound industry knowledge, thereby empowering the construction of medical institution alliances and the improvement of public healthcare system. Meanwhile, the Group will proactively enhance in-depth customer services, foster lean operation management and digital empowerment, follow national policies directions, and seize the opportunities in the medical testing service market, in order to provide the public with better and more efficient, more accurate and more competitive diagnostic testing products and services, thereby contributing to the realization of the blueprint for Healthy China 2030.– End –Yunkang Group Limited (Stock Code: 2325)Yunkang Group is a leading medical operation service provider in China, which started to provide standardized medical diagnostic services to medical institutions at all levels as early as 2008. Leveraging its own professional diagnostic capabilities and the nationwide service network of integrated healthcare systems, Yunkang has gradually grown to become a medical operation service platform. Meanwhile, Yunkang is a medical operation service provider in China offering a full suite of diagnostic testing services which are diagnostic outsourcing services and diagnostic testing services for medical institution alliances. Yunkang provides diagnostic services through on-site diagnostic centers to collaborative hospitals in the integrated healthcare systems in China and assists them in improving their clinical diagnosis capabilities through co-developing diagnostic centers. As of June 30, 2024, Yunkang has successfully provided professional services to over 430 medical institution alliances and the hospitals it collaborated with were located across 31 provinces and municipalities in China.Media InquiriesYunkang Group LimitedE-mail:ir@yunkanghealth.comWebsite:www.yunkanghealth.com Copyright 2024 ACN Newswire via SeaPRwire.com.
More